-
1
-
-
33747195353
-
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors
-
Takahashi, K.; Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126, 663–676.
-
(2006)
Cell
, vol.126
, pp. 663-676
-
-
Takahashi, K.1
Yamanaka, S.2
-
2
-
-
36248966518
-
Induction of pluripotent stem cells from adult human fibroblasts by defined factors
-
Takahashi, K.; Tanabe, K.; Ohnuki, M.; Narita, M.; Ichisaka, T.; Tomoda, K.; Yamanaka, S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131, 861–872.
-
(2007)
Cell
, vol.131
, pp. 861-872
-
-
Takahashi, K.1
Tanabe, K.2
Ohnuki, M.3
Narita, M.4
Ichisaka, T.5
Tomoda, K.6
Yamanaka, S.7
-
3
-
-
36749043230
-
Induced pluripotent stem cell lines derived from human somatic cells
-
Yu, J.; Vodyanik, M.A.; Smuga-Otto, K.; Antosiewicz-Bourget, J.; Frane, J.L.; Tian, S.; Nie, J.; Jonsdottir, G.A.; Ruotti, V.; Stewart, R. et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318, 1917–1920.
-
(2007)
Science
, vol.318
, pp. 1917-1920
-
-
Yu, J.1
Vodyanik, M.A.2
Smuga-Otto, K.3
Antosiewicz-Bourget, J.4
Frane, J.L.5
Tian, S.6
Nie, J.7
Jonsdottir, G.A.8
Ruotti, V.9
Stewart, R.10
-
4
-
-
48349095740
-
Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors
-
Kim, J.B.; Zaehres, H.; Wu, G.; Gentile, L.; Ko, K.; Sebastiano, V.; Arauzo-Bravo, M.J.; Ruau, D.; Han, D.W.; Zenke, M. et al. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature 2008, 454, 646–650.
-
(2008)
Nature
, vol.454
, pp. 646-650
-
-
Kim, J.B.1
Zaehres, H.2
Wu, G.3
Gentile, L.4
Ko, K.5
Sebastiano, V.6
Arauzo-Bravo, M.J.7
Ruau, D.8
Han, D.W.9
Zenke, M.10
-
5
-
-
43049084102
-
Enhanced efficiency of generating induced pluripotent stem (IPS) cells from human somatic cells by a combination of six transcription factors
-
Liao, J.; Wu, Z.; Wang, Y.; Cheng, L.; Cui, C.; Gao, Y.; Chen, T.; Rao, L.; Chen, S.; Jia, N. et al. Enhanced efficiency of generating induced pluripotent stem (iPS) cells from human somatic cells by a combination of six transcription factors. Cell Res. 2008, 18, 600–603.
-
(2008)
Cell Res
, vol.18
, pp. 600-603
-
-
Liao, J.1
Wu, Z.2
Wang, Y.3
Cheng, L.4
Cui, C.5
Gao, Y.6
Chen, T.7
Rao, L.8
Chen, S.9
Jia, N.10
-
6
-
-
79952899995
-
Methods for making induced pluripotent stem cells: Reprogramming à la carte
-
Gonzalez, F.; Boue, S.; Izpisua Belmonte, J.C. Methods for making induced pluripotent stem cells: Reprogramming à la carte. Nat. Rev. Genet. 2011, 12, 231–242.
-
(2011)
Nat. Rev. Genet
, vol.12
, pp. 231-242
-
-
Gonzalez, F.1
Boue, S.2
Izpisua Belmonte, J.C.3
-
7
-
-
77957671713
-
Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells
-
Seki, T.; Yuasa, S.; Oda, M.; Egashira, T.; Yae, K.; Kusumoto, D.; Nakata, H.; Tohyama, S.; Hashimoto, H.; Kodaira, M. et al. Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells. Cell Stem Cell 2010, 7, 11–14.
-
(2010)
Cell Stem Cell
, vol.7
, pp. 11-14
-
-
Seki, T.1
Yuasa, S.2
Oda, M.3
Egashira, T.4
Yae, K.5
Kusumoto, D.6
Nakata, H.7
Tohyama, S.8
Hashimoto, H.9
Kodaira, M.10
-
8
-
-
84861785745
-
Generation of induced pluripotent stem cells from a small amount of human peripheral blood using a combination of activated T cells and Sendai virus
-
Seki, T.; Yuasa, S.; Fukuda, K. Generation of induced pluripotent stem cells from a small amount of human peripheral blood using a combination of activated T cells and Sendai virus. Nat. Protoc. 2012, 7, 718–728.
-
(2012)
Nat. Protoc
, vol.7
, pp. 718-728
-
-
Seki, T.1
Yuasa, S.2
Fukuda, K.3
-
9
-
-
84896836202
-
Human pluripotent stem cell culture: Considerations for maintenance, expansion, and therapeutics
-
Chen, K.G.; Mallon, B.S.; McKay, R.D.; Robey, P.G. Human pluripotent stem cell culture: Considerations for maintenance, expansion, and therapeutics. Cell Stem Cell 2014, 14, 13–26.
-
(2014)
Cell Stem Cell
, vol.14
, pp. 13-26
-
-
Chen, K.G.1
Mallon, B.S.2
McKay, R.D.3
Robey, P.G.4
-
10
-
-
77951090909
-
Impacts of recent advances in cardiovascular regenerative medicine on clinical therapies and drug discovery
-
Murata, M.; Tohyama, S.; Fukuda, K. Impacts of recent advances in cardiovascular regenerative medicine on clinical therapies and drug discovery. Pharmacol. Ther. 2010, 126, 109–118.
-
(2010)
Pharmacol. Ther
, vol.126
, pp. 109-118
-
-
Murata, M.1
Tohyama, S.2
Fukuda, K.3
-
11
-
-
82455199147
-
Induced pluripotent stem cells—Opportunities for disease modelling and drug discovery
-
Grskovic, M.; Javaherian, A.; Strulovici, B.; Daley, G.Q. Induced pluripotent stem cells—Opportunities for disease modelling and drug discovery. Nat. Rev. Drug Discov. 2011, 10, 915–929.
-
(2011)
Nat. Rev. Drug Discov
, vol.10
, pp. 915-929
-
-
Grskovic, M.1
Javaherian, A.2
Strulovici, B.3
Daley, G.Q.4
-
12
-
-
79955572417
-
Harnessing the potential of induced pluripotent stem cells for regenerative medicine
-
Wu, S.M.; Hochedlinger, K. Harnessing the potential of induced pluripotent stem cells for regenerative medicine. Nat. Cell Biol. 2011, 13, 497–505.
-
(2011)
Nat. Cell Biol
, vol.13
, pp. 497-505
-
-
Wu, S.M.1
Hochedlinger, K.2
-
13
-
-
50549089957
-
Disease-specific induced pluripotent stem cells
-
Park, I.H.; Arora, N.; Huo, H.; Maherali, N.; Ahfeldt, T.; Shimamura, A.; Lensch, M.W.; Cowan, C.; Hochedlinger, K.; Daley, G.Q. Disease-specific induced pluripotent stem cells. Cell 2008, 134, 877–886.
-
(2008)
Cell
, vol.134
, pp. 877-886
-
-
Park, I.H.1
Arora, N.2
Huo, H.3
Maherali, N.4
Ahfeldt, T.5
Shimamura, A.6
Lensch, M.W.7
Cowan, C.8
Hochedlinger, K.9
Daley, G.Q.10
-
14
-
-
70450285340
-
Technical challenges in using human induced pluripotent stem cells to model disease
-
Saha, K.; Jaenisch, R. Technical challenges in using human induced pluripotent stem cells to model disease. Cell Stem Cell 2009, 5, 584–595.
-
(2009)
Cell Stem Cell
, vol.5
, pp. 584-595
-
-
Saha, K.1
Jaenisch, R.2
-
15
-
-
74949133926
-
Progress toward the clinical application of patient-specific pluripotent stem cells
-
Kiskinis, E.; Eggan, K. Progress toward the clinical application of patient-specific pluripotent stem cells. J. Clin. Investig. 2010, 120, 51–59.
-
(2010)
J. Clin. Investig
, vol.120
, pp. 51-59
-
-
Kiskinis, E.1
Eggan, K.2
-
16
-
-
84856112882
-
Diseases in a dish: Modeling human genetic disorders using induced pluripotent cells
-
Tiscornia, G.; Vivas, E.L.; Izpisua Belmonte, J.C. Diseases in a dish: Modeling human genetic disorders using induced pluripotent cells. Nat. Med. 2011, 17, 1570–1576.
-
(2011)
Nat. Med
, vol.17
, pp. 1570-1576
-
-
Tiscornia, G.1
Vivas, E.L.2
Izpisua Belmonte, J.C.3
-
17
-
-
55749089875
-
Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes
-
Aasen, T.; Raya, A.; Barrero, M.J.; Garreta, E.; Consiglio, A.; Gonzalez, F.; Vassena, R.; Bilic, J.; Pekarik, V.; Tiscornia, G. et al. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat. Biotechnol. 2008, 26, 1276–1284.
-
(2008)
Nat. Biotechnol
, vol.26
, pp. 1276-1284
-
-
Aasen, T.1
Raya, A.2
Barrero, M.J.3
Garreta, E.4
Consiglio, A.5
Gonzalez, F.6
Vassena, R.7
Bilic, J.8
Pekarik, V.9
Tiscornia, G.10
-
18
-
-
77957658573
-
Reprogramming of T cells from human peripheral blood
-
Loh, Y.H.; Hartung, O.; Li, H.; Guo, C.; Sahalie, J.M.; Manos, P.D.; Urbach, A.; Heffner, G.C.; Grskovic, M.; Vigneault, F. et al. Reprogramming of T cells from human peripheral blood. Cell Stem Cell 2010, 7, 15–19.
-
(2010)
Cell Stem Cell
, vol.7
, pp. 15-19
-
-
Loh, Y.H.1
Hartung, O.2
Li, H.3
Guo, C.4
Sahalie, J.M.5
Manos, P.D.6
Urbach, A.7
Heffner, G.C.8
Grskovic, M.9
Vigneault, F.10
-
19
-
-
77957671912
-
Reprogramming of human peripheral blood cells to induced pluripotent stem cells
-
Staerk, J.; Dawlaty, M.M.; Gao, Q.; Maetzel, D.; Hanna, J.; Sommer, C.A.; Mostoslavsky, G.; Jaenisch, R. Reprogramming of human peripheral blood cells to induced pluripotent stem cells. Cell Stem Cell 2010, 7, 20–24.
-
(2010)
Cell Stem Cell
, vol.7
, pp. 20-24
-
-
Staerk, J.1
Dawlaty, M.M.2
Gao, Q.3
Maetzel, D.4
Hanna, J.5
Sommer, C.A.6
Mostoslavsky, G.7
Jaenisch, R.8
-
20
-
-
38049028459
-
Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts
-
Nakagawa, M.; Koyanagi, M.; Tanabe, K.; Takahashi, K.; Ichisaka, T.; Aoi, T.; Okita, K.; Mochiduki, Y.; Takizawa, N.; Yamanaka, S. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat. Biotechnol. 2008, 26, 101–106.
-
(2008)
Nat. Biotechnol
, vol.26
, pp. 101-106
-
-
Nakagawa, M.1
Koyanagi, M.2
Tanabe, K.3
Takahashi, K.4
Ichisaka, T.5
Aoi, T.6
Okita, K.7
Mochiduki, Y.8
Takizawa, N.9
Yamanaka, S.10
-
21
-
-
55849115999
-
Induced pluripotent stem cells generated without viral integration
-
Stadtfeld, M.; Nagaya, M.; Utikal, J.; Weir, G.; Hochedlinger, K. Induced pluripotent stem cells generated without viral integration. Science 2008, 322, 945–949.
-
(2008)
Science
, vol.322
, pp. 945-949
-
-
Stadtfeld, M.1
Nagaya, M.2
Utikal, J.3
Weir, G.4
Hochedlinger, K.5
-
22
-
-
64749083939
-
PiggyBac transposition reprograms fibroblasts to induced pluripotent stem cells
-
Woltjen, K.; Michael, I.P.; Mohseni, P.; Desai, R.; Mileikovsky, M.; Hamalainen, R.; Cowling, R.; Wang, W.; Liu, P.; Gertsenstein, M. et al. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 2009, 458, 766–770.
-
(2009)
Nature
, vol.458
, pp. 766-770
-
-
Woltjen, K.1
Michael, I.P.2
Mohseni, P.3
Desai, R.4
Mileikovsky, M.5
Hamalainen, R.6
Cowling, R.7
Wang, W.8
Liu, P.9
Gertsenstein, M.10
-
23
-
-
64749111225
-
Virus-free induction of pluripotency and subsequent excision of reprogramming factors
-
Kaji, K.; Norrby, K.; Paca, A.; Mileikovsky, M.; Mohseni, P.; Woltjen, K. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 2009, 458, 771–775.
-
(2009)
Nature
, vol.458
, pp. 771-775
-
-
Kaji, K.1
Norrby, K.2
Paca, A.3
Mileikovsky, M.4
Mohseni, P.5
Woltjen, K.6
-
24
-
-
65649116572
-
Human induced pluripotent stem cells free of vector and transgene sequences
-
Yu, J.; Hu, K.; Smuga-Otto, K.; Tian, S.; Stewart, R.; Slukvin, I.I.; Thomson, J.A. Human induced pluripotent stem cells free of vector and transgene sequences. Science 2009, 324, 797–801.
-
(2009)
Science
, vol.324
, pp. 797-801
-
-
Yu, J.1
Hu, K.2
Smuga-Otto, K.3
Tian, S.4
Stewart, R.5
Slukvin, I.I.6
Thomson, J.A.7
-
25
-
-
66049135249
-
Zhu, Y. Et al. Generation of induced pluripotent stem cells using recombinant proteins
-
Zhou, H.; Wu, S.; Joo, J.Y.; Zhu, S.; Han, D.W.; Lin, T.; Trauger, S.; Bien, G.; Yao, S.; Zhu, Y. et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 2009, 4, 381–384.
-
(2009)
Cell Stem Cell
, vol.4
, pp. 381-384
-
-
Zhou, H.1
Wu, S.2
Joo, J.Y.3
Zhu, S.4
Han, D.W.5
Lin, T.6
Trauger, S.7
Bien, G.8
Yao, S.9
-
26
-
-
66049143859
-
Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins
-
Kim, D.; Kim, C.H.; Moon, J.I.; Chung, Y.G.; Chang, M.Y.; Han, B.S.; Ko, S.; Yang, E.; Cha, K.Y.; Lanza, R. et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 2009, 4, 472–476.
-
(2009)
Cell Stem Cell
, vol.4
, pp. 472-476
-
-
Kim, D.1
Kim, C.H.2
Moon, J.I.3
Chung, Y.G.4
Chang, M.Y.5
Han, B.S.6
Ko, S.7
Yang, E.8
Cha, K.Y.9
Lanza, R.10
-
27
-
-
77958536106
-
Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA
-
Warren, L.; Manos, P.D.; Ahfeldt, T.; Loh, Y.H.; Li, H.; Lau, F.; Ebina, W.; Mandal, P.K.; Smith, Z.D.; Meissner, A. et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 2010, 7, 618–630.
-
(2010)
Cell Stem Cell
, vol.7
, pp. 618-630
-
-
Warren, L.1
Manos, P.D.2
Ahfeldt, T.3
Loh, Y.H.4
Li, H.5
Lau, F.6
Ebina, W.7
Mandal, P.K.8
Smith, Z.D.9
Meissner, A.10
-
28
-
-
84862528505
-
Induced pluripotent stem cells: Past, present, and future
-
Yamanaka, S. Induced pluripotent stem cells: Past, present, and future. Cell Stem Cell 2012, 10, 678–684.
-
(2012)
Cell Stem Cell
, vol.10
, pp. 678-684
-
-
Yamanaka, S.1
-
29
-
-
84864243791
-
Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: A methods overview
-
Mummery, C.L.; Zhang, J.; Ng, E.S.; Elliott, D.A.; Elefanty, A.G.; Kamp, T.J. Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: A methods overview. Circ. Res. 2012, 111, 344–358.
-
(2012)
Circ. Res
, vol.111
, pp. 344-358
-
-
Mummery, C.L.1
Zhang, J.2
Ng, E.S.3
Elliott, D.A.4
Elefanty, A.G.5
Kamp, T.J.6
-
30
-
-
84877078624
-
Highly efficient directed differentiation of human induced pluripotent stem cells into cardiomyocytes
-
Burridge, P.W.; Zambidis, E.T. Highly efficient directed differentiation of human induced pluripotent stem cells into cardiomyocytes. Methods Mol. Biol. 2013, 997, 149–161.
-
(2013)
Methods Mol. Biol
, vol.997
, pp. 149-161
-
-
Burridge, P.W.1
Zambidis, E.T.2
-
31
-
-
0034136393
-
Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers
-
Itskovitz-Eldor, J.; Schuldiner, M.; Karsenti, D.; Eden, A.; Yanuka, O.; Amit, M.; Soreq, H.; Benvenisty, N. Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Mol. Med. 2000, 6, 88–95.
-
(2000)
Mol. Med
, vol.6
, pp. 88-95
-
-
Itskovitz-Eldor, J.1
Schuldiner, M.2
Karsenti, D.3
Eden, A.4
Yanuka, O.5
Amit, M.6
Soreq, H.7
Benvenisty, N.8
-
32
-
-
0034904645
-
Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes
-
Kehat, I.; Kenyagin-Karsenti, D.; Snir, M.; Segev, H.; Amit, M.; Gepstein, A.; Livne, E.; Binah, O.; Itskovitz-Eldor, J.; Gepstein, L. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J. Clin. Investig. 2001, 108, 407–414.
-
(2001)
J. Clin. Investig
, vol.108
, pp. 407-414
-
-
Kehat, I.1
Kenyagin-Karsenti, D.2
Snir, M.3
Segev, H.4
Amit, M.5
Gepstein, A.6
Livne, E.7
Binah, O.8
Itskovitz-Eldor, J.9
Gepstein, L.10
-
33
-
-
0037047695
-
Differentiation of pluripotent embryonic stem cells into cardiomyocytes
-
Boheler, K.R.; Czyz, J.; Tweedie, D.; Yang, H.T.; Anisimov, S.V.; Wobus, A.M. Differentiation of pluripotent embryonic stem cells into cardiomyocytes. Circ. Res. 2002, 91, 189–201.
-
(2002)
Circ. Res
, vol.91
, pp. 189-201
-
-
Boheler, K.R.1
Czyz, J.2
Tweedie, D.3
Yang, H.T.4
Anisimov, S.V.5
Wobus, A.M.6
-
34
-
-
0038210217
-
Differentiation of human embryonic stem cells to cardiomyocytes: Role of coculture with visceral endoderm-like cells
-
Mummery, C.; Ward-van Oostwaard, D.; Doevendans, P.; Spijker, R.; van den Brink, S.; Hassink, R.; van der Heyden, M.; Opthof, T.; Pera, M.; de la Riviere, A.B. et al. Differentiation of human embryonic stem cells to cardiomyocytes: Role of coculture with visceral endoderm-like cells. Circulation 2003, 107, 2733–2740.
-
(2003)
Circulation
, vol.107
, pp. 2733-2740
-
-
Mummery, C.1
Ward-Van Oostwaard, D.2
Doevendans, P.3
Spijker, R.4
Van Den Brink, S.5
Hassink, R.6
Van Der Heyden, M.7
Opthof, T.8
Pera, M.9
De La Riviere, A.B.10
-
35
-
-
22844439586
-
Transient inhibition of BMP signaling by Noggin induces cardiomyocyte differentiation of mouse embryonic stem cells
-
Yuasa, S.; Itabashi, Y.; Koshimizu, U.; Tanaka, T.; Sugimura, K.; Kinoshita, M.; Hattori, F.; Fukami, S.; Shimazaki, T.; Ogawa, S. et al. Transient inhibition of BMP signaling by Noggin induces cardiomyocyte differentiation of mouse embryonic stem cells. Nat. Biotechnol. 2005, 23, 607–611.
-
(2005)
Nat. Biotechnol
, vol.23
, pp. 607-611
-
-
Yuasa, S.1
Itabashi, Y.2
Koshimizu, U.3
Tanaka, T.4
Sugimura, K.5
Kinoshita, M.6
Hattori, F.7
Fukami, S.8
Shimazaki, T.9
Ogawa, S.10
-
36
-
-
39349106325
-
Differentiation of embryonic stem cells to clinically relevant populations
-
Murry, C.E.; Keller, G. Differentiation of embryonic stem cells to clinically relevant populations: Lessons from embryonic development. Cell 2008, 132, 661–680.
-
(2008)
Lessons from Embryonic Development. Cell
, vol.132
, pp. 661-680
-
-
Murry, C.E.1
Keller, G.2
-
37
-
-
44349175948
-
Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population
-
Yang, L.; Soonpaa, M.H.; Adler, E.D.; Roepke, T.K.; Kattman, S.J.; Kennedy, M.; Henckaerts, E.; Bonham, K.; Abbott, G.W.; Linden, R.M. et al. Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature 2008, 453, 524–528.
-
(2008)
Nature
, vol.453
, pp. 524-528
-
-
Yang, L.1
Soonpaa, M.H.2
Adler, E.D.3
Roepke, T.K.4
Kattman, S.J.5
Kennedy, M.6
Henckaerts, E.7
Bonham, K.8
Abbott, G.W.9
Linden, R.M.10
-
38
-
-
53349091628
-
Defining early lineage specification of human embryonic stem cells by the orchestrated balance of canonical Wnt/β-catenin, Activin/Nodal and BMP signaling
-
Sumi, T.; Tsuneyoshi, N.; Nakatsuji, N.; Suemori, H. Defining early lineage specification of human embryonic stem cells by the orchestrated balance of canonical Wnt/β-catenin, Activin/Nodal and BMP signaling. Development 2008, 135, 2969–2979.
-
(2008)
Development
, vol.135
, pp. 2969-2979
-
-
Sumi, T.1
Tsuneyoshi, N.2
Nakatsuji, N.3
Suemori, H.4
-
39
-
-
79551597211
-
Stage-specific optimization of Activin/Nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines
-
Kattman, S.J.; Witty, A.D.; Gagliardi, M.; Dubois, N.C.; Niapour, M.; Hotta, A.; Ellis, J.; Keller, G. Stage-specific optimization of Activin/Nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell 2011, 8, 228–240.
-
(2011)
Cell Stem Cell
, vol.8
, pp. 228-240
-
-
Kattman, S.J.1
Witty, A.D.2
Gagliardi, M.3
Dubois, N.C.4
Niapour, M.5
Hotta, A.6
Ellis, J.7
Keller, G.8
-
40
-
-
80051796581
-
Small-molecule inhibitors of the Wnt pathway potently promote cardiomyocytes from human embryonic stem cell-derived mesoderm
-
Willems, E.; Spiering, S.; Davidovics, H.; Lanier, M.; Xia, Z.; Dawson, M.; Cashman, J.; Mercola, M. Small-molecule inhibitors of the Wnt pathway potently promote cardiomyocytes from human embryonic stem cell-derived mesoderm. Circ. Res. 2011, 109, 360–364.
-
(2011)
Circ. Res
, vol.109
, pp. 360-364
-
-
Willems, E.1
Spiering, S.2
Davidovics, H.3
Lanier, M.4
Xia, Z.5
Dawson, M.6
Cashman, J.7
Mercola, M.8
-
41
-
-
79960913156
-
Small molecule Wnt inhibitors enhance the efficiency of BMP-4-directed cardiac differentiation of human pluripotent stem cells
-
Ren, Y.; Lee, M.Y.; Schliffke, S.; Paavola, J.; Amos, P.J.; Ge, X.; Ye, M.; Zhu, S.; Senyei, G.; Lum, L. et al. Small molecule Wnt inhibitors enhance the efficiency of BMP-4-directed cardiac differentiation of human pluripotent stem cells. J. Mol. Cell. Cardiol. 2011, 51, 280–287.
-
(2011)
J. Mol. Cell. Cardiol
, vol.51
, pp. 280-287
-
-
Ren, Y.1
Lee, M.Y.2
Schliffke, S.3
Paavola, J.4
Amos, P.J.5
Ge, X.6
Ye, M.7
Zhu, S.8
Senyei, G.9
Lum, L.10
-
42
-
-
80051847166
-
Efficient and scalable purification of cardiomyocytes from human embryonic and induced pluripotent stem cells by VCAM1 surface expression
-
Uosaki, H.; Fukushima, H.; Takeuchi, A.; Matsuoka, S.; Nakatsuji, N.; Yamanaka, S.; Yamashita, J.K. Efficient and scalable purification of cardiomyocytes from human embryonic and induced pluripotent stem cells by VCAM1 surface expression. PLoS ONE 2011, 6, 23657.
-
(2011)
Plos ONE
, vol.6
, pp. 23657
-
-
Uosaki, H.1
Fukushima, H.2
Takeuchi, A.3
Matsuoka, S.4
Nakatsuji, N.5
Yamanaka, S.6
Yamashita, J.K.7
-
43
-
-
84872016692
-
Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions
-
Lian, X.; Zhang, J.; Azarin, S.M.; Zhu, K.; Hazeltine, L.B.; Bao, X.; Hsiao, C.; Kamp, T.J.; Palecek, S.P. Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions. Nat. Protoc. 2013, 8, 162–175.
-
(2013)
Nat. Protoc
, vol.8
, pp. 162-175
-
-
Lian, X.1
Zhang, J.2
Azarin, S.M.3
Zhu, K.4
Hazeltine, L.B.5
Bao, X.6
Hsiao, C.7
Kamp, T.J.8
Palecek, S.P.9
-
44
-
-
61949300076
-
Functional cardiomyocytes derived from human induced pluripotent stem cells
-
Zhang, J.; Wilson, G.F.; Soerens, A.G.; Koonce, C.H.; Yu, J.; Palecek, S.P.; Thomson, J.A.; Kamp, T.J. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ. Res. 2009, 104, e30–e41.
-
(2009)
Circ. Res
, vol.104
, pp. 30-41
-
-
Zhang, J.1
Wilson, G.F.2
Soerens, A.G.3
Koonce, C.H.4
Yu, J.5
Palecek, S.P.6
Thomson, J.A.7
Kamp, T.J.8
-
45
-
-
67349123365
-
In vitro pharmacologic testing using human induced pluripotent stem cell-derived cardiomyocytes
-
Tanaka, T.; Tohyama, S.; Murata, M.; Nomura, F.; Kaneko, T.; Chen, H.; Hattori, F.; Egashira, T.; Seki, T.; Ohno, Y. et al. In vitro pharmacologic testing using human induced pluripotent stem cell-derived cardiomyocytes. Biochem. Biophys. Res. Commun. 2009, 385, 497–502.
-
(2009)
Biochem. Biophys. Res. Commun
, vol.385
, pp. 497-502
-
-
Tanaka, T.1
Tohyama, S.2
Murata, M.3
Nomura, F.4
Kaneko, T.5
Chen, H.6
Hattori, F.7
Egashira, T.8
Seki, T.9
Ohno, Y.10
-
46
-
-
70350135472
-
Cardiomyocyte differentiation of human induced pluripotent stem cells
-
Zwi, L.; Caspi, O.; Arbel, G.; Huber, I.; Gepstein, A.; Park, I.H.; Gepstein, L. Cardiomyocyte differentiation of human induced pluripotent stem cells. Circulation 2009, 120, 1513–1523.
-
(2009)
Circulation
, vol.120
, pp. 1513-1523
-
-
Zwi, L.1
Caspi, O.2
Arbel, G.3
Huber, I.4
Gepstein, A.5
Park, I.H.6
Gepstein, L.7
-
47
-
-
78751687308
-
Molecular characterization and functional properties of cardiomyocytes derived from human inducible pluripotent stem cells
-
Germanguz, I.; Sedan, O.; Zeevi-Levin, N.; Shtrichman, R.; Barak, E.; Ziskind, A.; Eliyahu, S.; Meiry, G.; Amit, M.; Itskovitz-Eldor, J. et al. Molecular characterization and functional properties of cardiomyocytes derived from human inducible pluripotent stem cells. J. Cell Mol. Med. 2011, 15, 38–51.
-
(2011)
J. Cell Mol. Med
, vol.15
, pp. 38-51
-
-
Germanguz, I.1
Sedan, O.2
Zeevi-Levin, N.3
Shtrichman, R.4
Barak, E.5
Ziskind, A.6
Eliyahu, S.7
Meiry, G.8
Amit, M.9
Itskovitz-Eldor, J.10
-
48
-
-
79953655401
-
Calcium handling in human induced pluripotent stem cell derived cardiomyocytes
-
Itzhaki, I.; Rapoport, S.; Huber, I.; Mizrahi, I.; Zwi-Dantsis, L.; Arbel, G.; Schiller, J.; Gepstein, L. Calcium handling in human induced pluripotent stem cell derived cardiomyocytes. PLoS ONE 2011, 6, 18037.
-
(2011)
Plos ONE
, vol.6
, pp. 18037
-
-
Itzhaki, I.1
Rapoport, S.2
Huber, I.3
Mizrahi, I.4
Zwi-Dantsis, L.5
Arbel, G.6
Schiller, J.7
Gepstein, L.8
-
49
-
-
82355168775
-
Calcium homeostasis in human induced pluripotent stem cell-derived cardiomyocytes
-
Lee, Y.K.; Ng, K.M.; Lai, W.H.; Chan, Y.C.; Lau, Y.M.; Lian, Q.; Tse, H.F.; Siu, C.W. Calcium homeostasis in human induced pluripotent stem cell-derived cardiomyocytes. Stem Cell Rev. 2011, 7, 976–986.
-
(2011)
Stem Cell Rev
, vol.7
, pp. 976-986
-
-
Lee, Y.K.1
Ng, K.M.2
Lai, W.H.3
Chan, Y.C.4
Lau, Y.M.5
Lian, Q.6
Tse, H.F.7
Siu, C.W.8
-
50
-
-
84886778845
-
Calcium signalling of human pluripotent stem cell-derived cardiomyocytes
-
Li, S.; Chen, G.; Li, R.A. Calcium signalling of human pluripotent stem cell-derived cardiomyocytes. J. Physiol. 2013, 591, 5279–5290.
-
(2013)
J. Physiol
, vol.591
, pp. 5279-5290
-
-
Li, S.1
Chen, G.2
Li, R.A.3
-
51
-
-
84908105780
-
Generation and characterization of functional cardiomyocytes derived from human t cell-derived induced pluripotent stem cells
-
Seki, T.; Yuasa, S.; Kusumoto, D.; Kunitomi, A.; Saito, Y.; Tohyama, S.; Yae, K.; Kishino, Y.; Okada, M.; Hashimoto, H. et al. Generation and characterization of functional cardiomyocytes derived from human t cell-derived induced pluripotent stem cells. PLoS ONE 2014, 9, 85645.
-
(2014)
Plos ONE
, vol.9
, pp. 85645
-
-
Seki, T.1
Yuasa, S.2
Kusumoto, D.3
Kunitomi, A.4
Saito, Y.5
Tohyama, S.6
Yae, K.7
Kishino, Y.8
Okada, M.9
Hashimoto, H.10
-
52
-
-
84878109700
-
Cellular reprogramming to reset epigenetic signatures
-
Hewitt, K.J.; Garlick, J.A. Cellular reprogramming to reset epigenetic signatures. Mol. Asp. Med. 2013, 34, 841–848.
-
(2013)
Mol. Asp. Med
, vol.34
, pp. 841-848
-
-
Hewitt, K.J.1
Garlick, J.A.2
-
53
-
-
84919764228
-
Disease modeling and phenotypic drug screening for diabetic cardiomyopathy using human induced pluripotent stem cells
-
Drawnel, F.M.; Boccardo, S.; Prummer, M.; Delobel, F.; Graff, A.; Weber, M.; Gerard, R.; Badi, L.; Kam-Thong, T.; Bu, L. et al. Disease modeling and phenotypic drug screening for diabetic cardiomyopathy using human induced pluripotent stem cells. Cell Rep. 2014, 9, 810–821.
-
(2014)
Cell Rep
, vol.9
, pp. 810-821
-
-
Drawnel, F.M.1
Boccardo, S.2
Prummer, M.3
Delobel, F.4
Graff, A.5
Weber, M.6
Gerard, R.7
Badi, L.8
Kam-Thong, T.9
Bu, L.10
-
54
-
-
40449141341
-
Marked differences in differentiation propensity among human embryonic stem cell lines
-
Osafune, K.; Caron, L.; Borowiak, M.; Martinez, R.J.; Fitz-Gerald, C.S.; Sato, Y.; Cowan, C.A.; Chien, K.R.; Melton, D.A. Marked differences in differentiation propensity among human embryonic stem cell lines. Nat. Biotechnol. 2008, 26, 313–315.
-
(2008)
Nat. Biotechnol
, vol.26
, pp. 313-315
-
-
Osafune, K.1
Caron, L.2
Borowiak, M.3
Martinez, R.J.4
Fitz-Gerald, C.S.5
Sato, Y.6
Cowan, C.A.7
Chien, K.R.8
Melton, D.A.9
-
55
-
-
77955449906
-
Epigenetic memory in induced pluripotent stem cells
-
Kim, K.; Doi, A.; Wen, B.; Ng, K.; Zhao, R.; Cahan, P.; Kim, J.; Aryee, M.J.; Ji, H.; Ehrlich, L.I. et al. Epigenetic memory in induced pluripotent stem cells. Nature 2010, 467, 285–290.
-
(2010)
Nature
, vol.467
, pp. 285-290
-
-
Kim, K.1
Doi, A.2
Wen, B.3
Ng, K.4
Zhao, R.5
Cahan, P.6
Kim, J.7
Aryee, M.J.8
Ji, H.9
Ehrlich, L.I.10
-
56
-
-
79959992876
-
Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet β cells
-
Bar-Nur, O.; Russ, H.A.; Efrat, S.; Benvenisty, N. Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet β cells. Cell Stem Cell 2011, 9, 17–23.
-
(2011)
Cell Stem Cell
, vol.9
, pp. 17-23
-
-
Bar-Nur, O.1
Russ, H.A.2
Efrat, S.3
Benvenisty, N.4
-
57
-
-
79960833952
-
Generation of isogenic pluripotent stem cells differing exclusively at two early onset parkinson point mutations
-
Soldner, F.; Laganiere, J.; Cheng, A.W.; Hockemeyer, D.; Gao, Q.; Alagappan, R.; Khurana, V.; Golbe, L.I.; Myers, R.H.; Lindquist, S. et al. Generation of isogenic pluripotent stem cells differing exclusively at two early onset parkinson point mutations. Cell 2011, 146, 318–331.
-
(2011)
Cell
, vol.146
, pp. 318-331
-
-
Soldner, F.1
Laganiere, J.2
Cheng, A.W.3
Hockemeyer, D.4
Gao, Q.5
Alagappan, R.6
Khurana, V.7
Golbe, L.I.8
Myers, R.H.9
Lindquist, S.10
-
58
-
-
84890563877
-
Isogenic human pluripotent stem cell pairs reveal the role of a KCNH2 mutation in long-QT syndrome
-
Bellin, M.; Casini, S.; Davis, R.P.; D’Aniello, C.; Haas, J.; Ward-van Oostwaard, D.; Tertoolen, L.G.; Jung, C.B.; Elliott, D.A.; Welling, A. et al. Isogenic human pluripotent stem cell pairs reveal the role of a KCNH2 mutation in long-QT syndrome. EMBO J. 2013, 32, 3161–3175.
-
(2013)
EMBO J
, vol.32
, pp. 3161-3175
-
-
Bellin, M.1
Casini, S.2
Davis, R.P.3
D’Aniello, C.4
Haas, J.5
Ward-Van Oostwaard, D.6
Tertoolen, L.G.7
Jung, C.B.8
Elliott, D.A.9
Welling, A.10
-
59
-
-
84902087268
-
Modeling the mitochondrial cardiomyopathy of barth syndrome with induced pluripotent stem cell and heart-on-chip technologies
-
Wang, G.; McCain, M.L.; Yang, L.; He, A.; Pasqualini, F.S.; Agarwal, A.; Yuan, H.; Jiang, D.; Zhang, D.; Zangi, L. et al. Modeling the mitochondrial cardiomyopathy of barth syndrome with induced pluripotent stem cell and heart-on-chip technologies. Nat. Med. 2014, 20, 616–623.
-
(2014)
Nat. Med
, vol.20
, pp. 616-623
-
-
Wang, G.1
McCain, M.L.2
Yang, L.3
He, A.4
Pasqualini, F.S.5
Agarwal, A.6
Yuan, H.7
Jiang, D.8
Zhang, D.9
Zangi, L.10
-
60
-
-
77957670482
-
Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in parkinsonian rats
-
Hargus, G.; Cooper, O.; Deleidi, M.; Levy, A.; Lee, K.; Marlow, E.; Yow, A.; Soldner, F.; Hockemeyer, D.; Hallett, P.J. et al. Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in parkinsonian rats. Proc. Natl. Acad. Sci. USA 2010, 107, 15921–15926.
-
(2010)
Proc. Natl. Acad. Sci. USA
, vol.107
, pp. 15921-15926
-
-
Hargus, G.1
Cooper, O.2
Deleidi, M.3
Levy, A.4
Lee, K.5
Marlow, E.6
Yow, A.7
Soldner, F.8
Hockemeyer, D.9
Hallett, P.J.10
-
61
-
-
84866466228
-
Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model
-
Kawamura, M.; Miyagawa, S.; Miki, K.; Saito, A.; Fukushima, S.; Higuchi, T.; Kawamura, T.; Kuratani, T.; Daimon, T.; Shimizu, T. et al. Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model. Circulation 2012, 126, S29–S37.
-
(2012)
Circulation
, vol.126
, pp. 29-37
-
-
Kawamura, M.1
Miyagawa, S.2
Miki, K.3
Saito, A.4
Fukushima, S.5
Higuchi, T.6
Kawamura, T.7
Kuratani, T.8
Daimon, T.9
Shimizu, T.10
-
62
-
-
84871529372
-
Genetic correction of human induced pluripotent stem cells from patients with spinal muscular atrophy
-
Corti, S.; Nizzardo, M.; Simone, C.; Falcone, M.; Nardini, M.; Ronchi, D.; Donadoni, C.; Salani, S.; Riboldi, G.; Magri, F. et al. Genetic correction of human induced pluripotent stem cells from patients with spinal muscular atrophy. Sci. Transl. Med. 2012, 4, doi:10.1126/scitranslmed.300410.
-
(2012)
Sci. Transl. Med
, pp. 4
-
-
Corti, S.1
Nizzardo, M.2
Simone, C.3
Falcone, M.4
Nardini, M.5
Ronchi, D.6
Donadoni, C.7
Salani, S.8
Riboldi, G.9
Magri, F.10
-
63
-
-
84883770184
-
Enhanced survival of transplanted human induced pluripotent stem cell-derived cardiomyocytes by the combination of cell sheets with the pedicled omental flap technique in a porcine heart
-
Kawamura, M.; Miyagawa, S.; Fukushima, S.; Saito, A.; Miki, K.; Ito, E.; Sougawa, N.; Kawamura, T.; Daimon, T.; Shimizu, T. et al. Enhanced survival of transplanted human induced pluripotent stem cell-derived cardiomyocytes by the combination of cell sheets with the pedicled omental flap technique in a porcine heart. Circulation 2013, 128, S87–S94.
-
(2013)
Circulation
, vol.128
, pp. 87-94
-
-
Kawamura, M.1
Miyagawa, S.2
Fukushima, S.3
Saito, A.4
Miki, K.5
Ito, E.6
Sougawa, N.7
Kawamura, T.8
Daimon, T.9
Shimizu, T.10
-
64
-
-
84893748014
-
Characterization of human induced pluripotent stem cell-derived retinal pigment epithelium cell sheets aiming for clinical application
-
Kamao, H.; Mandai, M.; Okamoto, S.; Sakai, N.; Suga, A.; Sugita, S.; Kiryu, J.; Takahashi, M. Characterization of human induced pluripotent stem cell-derived retinal pigment epithelium cell sheets aiming for clinical application. Stem Cell Rep. 2014, 2, 205–218.
-
(2014)
Stem Cell Rep
, vol.2
, pp. 205-218
-
-
Kamao, H.1
Mandai, M.2
Okamoto, S.3
Sakai, N.4
Suga, A.5
Sugita, S.6
Kiryu, J.7
Takahashi, M.8
-
65
-
-
84896105350
-
Advances in stem-cell--generated transplantation therapy for parkinson’s disease
-
Sundberg, M.; Isacson, O. Advances in stem-cell--generated transplantation therapy for parkinson’s disease. Expert Opin. Biol. Ther. 2014, 14, 437–453.
-
(2014)
Expert Opin. Biol. Ther
, vol.14
, pp. 437-453
-
-
Sundberg, M.1
Isacson, O.2
-
66
-
-
84929265416
-
Ex vivo gene therapy using patient iPSC-derived NSCs reverses pathology in the brain of a homologous mouse model
-
Griffin, T.A.; Anderson, H.C.; Wolfe, J.H. Ex vivo gene therapy using patient iPSC-derived NSCs reverses pathology in the brain of a homologous mouse model. Stem Cell Rep. 2015, 4, 835–846.
-
(2015)
Stem Cell Rep
, vol.4
, pp. 835-846
-
-
Griffin, T.A.1
Anderson, H.C.2
Wolfe, J.H.3
-
67
-
-
84857425568
-
Cardiac safety pharmacology: From human ether-a-gogo related gene channel block towards induced pluripotent stem cell based disease models
-
Kraushaar, U.; Meyer, T.; Hess, D.; Gepstein, L.; Mummery, C.L.; Braam, S.R.; Guenther, E. Cardiac safety pharmacology: From human ether-a-gogo related gene channel block towards induced pluripotent stem cell based disease models. Expert. Opin. Drug Saf. 2012, 11, 285–298.
-
(2012)
Expert. Opin. Drug Saf
, vol.11
, pp. 285-298
-
-
Kraushaar, U.1
Meyer, T.2
Hess, D.3
Gepstein, L.4
Mummery, C.L.5
Braam, S.R.6
Guenther, E.7
-
68
-
-
84866385460
-
Novel stem cell-based drug discovery platforms for cardiovascular disease
-
Adams, W.J.; Garcia-Cardena, G. Novel stem cell-based drug discovery platforms for cardiovascular disease. J. Biomol. Screen. 2012, 17, 1117–1127.
-
(2012)
J. Biomol. Screen
, vol.17
, pp. 1117-1127
-
-
Adams, W.J.1
Garcia-Cardena, G.2
-
69
-
-
84873353816
-
Induced pluripotent stem cells in cardiovascular drug discovery
-
Mercola, M.; Colas, A.; Willems, E. Induced pluripotent stem cells in cardiovascular drug discovery. Circ. Res. 2013, 112, 534–548.
-
(2013)
Circ. Res
, vol.112
, pp. 534-548
-
-
Mercola, M.1
Colas, A.2
Willems, E.3
-
70
-
-
84872599837
-
A review of human pluripotent stem cell-derived cardiomyocytes for high-throughput drug discovery, cardiotoxicity screening, and publication standards
-
Mordwinkin, N.M.; Burridge, P.W.; Wu, J.C. A review of human pluripotent stem cell-derived cardiomyocytes for high-throughput drug discovery, cardiotoxicity screening, and publication standards. J. Cardiovasc. Transl. Res. 2013, 6, 22–30.
-
(2013)
J. Cardiovasc. Transl. Res
, vol.6
, pp. 22-30
-
-
Mordwinkin, N.M.1
Burridge, P.W.2
Wu, J.C.3
-
71
-
-
84876526111
-
Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity
-
Liang, P.; Lan, F.; Lee, A.S.; Gong, T.; Sanchez-Freire, V.; Wang, Y.; Diecke, S.; Sallam, K.; Knowles, J.W.; Wang, P.J. et al. Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity. Circulation 2013, 127, 1677–1691.
-
(2013)
Circulation
, vol.127
, pp. 1677-1691
-
-
Liang, P.1
Lan, F.2
Lee, A.S.3
Gong, T.4
Sanchez-Freire, V.5
Wang, Y.6
Diecke, S.7
Sallam, K.8
Knowles, J.W.9
Wang, P.J.10
-
72
-
-
50149098605
-
Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons
-
Dimos, J.T.; Rodolfa, K.T.; Niakan, K.K.; Weisenthal, L.M.; Mitsumoto, H.; Chung, W.; Croft, G.F.; Saphier, G.; Leibel, R.; Goland, R. et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 2008, 321, 1218–1221.
-
(2008)
Science
, vol.321
, pp. 1218-1221
-
-
Dimos, J.T.1
Rodolfa, K.T.2
Niakan, K.K.3
Weisenthal, L.M.4
Mitsumoto, H.5
Chung, W.6
Croft, G.F.7
Saphier, G.8
Leibel, R.9
Goland, R.10
-
73
-
-
58249110796
-
Induced pluripotent stem cells from a spinal muscular atrophy patient
-
Ebert, A.D.; Yu, J.; Rose, F.F., Jr.; Mattis, V.B.; Lorson, C.L.; Thomson, J.A.; Svendsen, C.N. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 2009, 457, 277–280.
-
(2009)
Nature
, vol.457
, pp. 277-280
-
-
Ebert, A.D.1
Yu, J.2
Rose, F.F.3
Mattis, V.B.4
Lorson, C.L.5
Thomson, J.A.6
Svendsen, C.N.7
-
74
-
-
70349301819
-
Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs
-
Lee, G.; Papapetrou, E.P.; Kim, H.; Chambers, S.M.; Tomishima, M.J.; Fasano, C.A.; Ganat, Y.M.; Menon, J.; Shimizu, F.; Viale, A. et al. Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature 2009, 461, 402–406.
-
(2009)
Nature
, vol.461
, pp. 402-406
-
-
Lee, G.1
Papapetrou, E.P.2
Kim, H.3
Chambers, S.M.4
Tomishima, M.J.5
Fasano, C.A.6
Ganat, Y.M.7
Menon, J.8
Shimizu, F.9
Viale, A.10
-
75
-
-
79952172335
-
LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress
-
Nguyen, H.N.; Byers, B.; Cord, B.; Shcheglovitov, A.; Byrne, J.; Gujar, P.; Kee, K.; Schule, B.; Dolmetsch, R.E.; Langston, W. et al. LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress. Cell Stem Cell 2011, 8, 267–280.
-
(2011)
Cell Stem Cell
, vol.8
, pp. 267-280
-
-
Nguyen, H.N.1
Byers, B.2
Cord, B.3
Shcheglovitov, A.4
Byrne, J.5
Gujar, P.6
Kee, K.7
Schule, B.8
Dolmetsch, R.E.9
Langston, W.10
-
76
-
-
81255169342
-
Modeling familial Alzheimer’s disease with induced pluripotent stem cells
-
Yagi, T.; Ito, D.; Okada, Y.; Akamatsu, W.; Nihei, Y.; Yoshizaki, T.; Yamanaka, S.; Okano, H.; Suzuki, N. Modeling familial Alzheimer’s disease with induced pluripotent stem cells. Hum. Mol. Genet. 2011, 20, 4530–4539.
-
(2011)
Hum. Mol. Genet
, vol.20
, pp. 4530-4539
-
-
Yagi, T.1
Ito, D.2
Okada, Y.3
Akamatsu, W.4
Nihei, Y.5
Yoshizaki, T.6
Yamanaka, S.7
Okano, H.8
Suzuki, N.9
-
77
-
-
84875916922
-
Okita, K. Et al. Modeling Alzheimer’s disease with iPSCs reveals stress phenotypes associated with intracellular Aβ and differential drug responsiveness
-
Kondo, T.; Asai, M.; Tsukita, K.; Kutoku, Y.; Ohsawa, Y.; Sunada, Y.; Imamura, K.; Egawa, N.; Yahata, N.; Okita, K. et al. Modeling Alzheimer’s disease with iPSCs reveals stress phenotypes associated with intracellular Aβ and differential drug responsiveness. Cell Stem Cell 2013, 12, 487–496.
-
(2013)
Cell Stem Cell
, vol.12
, pp. 487-496
-
-
Kondo, T.1
Asai, M.2
Tsukita, K.3
Kutoku, Y.4
Ohsawa, Y.5
Sunada, Y.6
Imamura, K.7
Egawa, N.8
Yahata, N.9
-
78
-
-
84890067639
-
Modeling induced pluripotent stem cells from fibroblasts of duchenne muscular dystrophy patients
-
Luo, Y.; Fan, Y.; Chen, X.; Yue, L.; Yu, B.; Li, Q.; Chen, Y.; Sun, X. Modeling induced pluripotent stem cells from fibroblasts of duchenne muscular dystrophy patients. Int. J. Neurosci. 2014, 124, 12–21.
-
(2014)
Int. J. Neurosci
, vol.124
, pp. 12-21
-
-
Luo, Y.1
Fan, Y.2
Chen, X.3
Yue, L.4
Yu, B.5
Li, Q.6
Chen, Y.7
Sun, X.8
-
79
-
-
70349437501
-
Generation of pluripotent stem cells from patients with type 1 diabetes
-
Maehr, R.; Chen, S.; Snitow, M.; Ludwig, T.; Yagasaki, L.; Goland, R.; Leibel, R.L.; Melton, D.A. Generation of pluripotent stem cells from patients with type 1 diabetes. Proc. Natl. Acad. Sci. USA 2009, 106, 15768–15773.
-
(2009)
Proc. Natl. Acad. Sci. USA
, vol.106
, pp. 15768-15773
-
-
Maehr, R.1
Chen, S.2
Snitow, M.3
Ludwig, T.4
Yagasaki, L.5
Goland, R.6
Leibel, R.L.7
Melton, D.A.8
-
80
-
-
77956354416
-
Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells
-
Rashid, S.T.; Corbineau, S.; Hannan, N.; Marciniak, S.J.; Miranda, E.; Alexander, G.; Huang-Doran, I.; Griffin, J.; Ahrlund-Richter, L.; Skepper, J. et al. Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells. J. Clin. Investig. 2010, 120, 3127–3136.
-
(2010)
J. Clin. Investig
, vol.120
, pp. 3127-3136
-
-
Rashid, S.T.1
Corbineau, S.2
Hannan, N.3
Marciniak, S.J.4
Miranda, E.5
Alexander, G.6
Huang-Doran, I.7
Griffin, J.8
Ahrlund-Richter, L.9
Skepper, J.10
-
81
-
-
67650095306
-
Disease-corrected haematopoietic progenitors from fanconi anaemia induced pluripotent stem cells
-
Raya, A.; Rodriguez-Piza, I.; Guenechea, G.; Vassena, R.; Navarro, S.; Barrero, M.J.; Consiglio, A.; Castella, M.; Rio, P.; Sleep, E. et al. Disease-corrected haematopoietic progenitors from fanconi anaemia induced pluripotent stem cells. Nature 2009, 460, 53–59.
-
(2009)
Nature
, vol.460
, pp. 53-59
-
-
Raya, A.1
Rodriguez-Piza, I.2
Guenechea, G.3
Vassena, R.4
Navarro, S.5
Barrero, M.J.6
Consiglio, A.7
Castella, M.8
Rio, P.9
Sleep, E.10
-
82
-
-
79957868170
-
-
Pessach, I.M.; Ordovas-Montanes, J.; Zhang, S.Y.; Casanova, J.L.; Giliani, S.; Gennery, A.R.; Al-Herz, W.; Manos, P.D.; Schlaeger, T.M.; Park, I.H. et al. Induced pluripotent stem cells: A novel frontier in the study of human primary immunodeficiencies. J. Allergy Clin. Immunol. 2011, 127, 1400–1407.
-
(2011)
Induced Pluripotent Stem Cells: A Novel Frontier in the Study of Human Primary Immunodeficiencies. J. Allergy Clin. Immunol
, vol.127
, pp. 1400-1407
-
-
Pessach, I.M.1
Ordovas-Montanes, J.2
Zhang, S.Y.3
Casanova, J.L.4
Giliani, S.5
Gennery, A.R.6
Al-Herz, W.7
Manos, P.D.8
Schlaeger, T.M.9
Park, I.H.10
-
83
-
-
84863505092
-
Generation of induced pluripotent stem cells from primary chronic myelogenous leukemia patient samples
-
Kumano, K.; Arai, S.; Hosoi, M.; Taoka, K.; Takayama, N.; Otsu, M.; Nagae, G.; Ueda, K.; Nakazaki, K.; Kamikubo, Y. et al. Generation of induced pluripotent stem cells from primary chronic myelogenous leukemia patient samples. Blood 2012, 119, 6234–6242.
-
(2012)
Blood
, vol.119
, pp. 6234-6242
-
-
Kumano, K.1
Arai, S.2
Hosoi, M.3
Taoka, K.4
Takayama, N.5
Otsu, M.6
Nagae, G.7
Ueda, K.8
Nakazaki, K.9
Kamikubo, Y.10
-
84
-
-
84885041970
-
Reduced ciliary polycystin-2 in induced pluripotent stem cells from polycystic kidney disease patients with PKD1 mutations
-
Freedman, B.S.; Lam, A.Q.; Sundsbak, J.L.; Iatrino, R.; Su, X.; Koon, S.J.; Wu, M.; Daheron, L.; Harris, P.C.; Zhou, J. et al. Reduced ciliary polycystin-2 in induced pluripotent stem cells from polycystic kidney disease patients with PKD1 mutations. J. Am. Soc. Nephrol. 2013, 24, 1571–1586.
-
(2013)
J. Am. Soc. Nephrol
, vol.24
, pp. 1571-1586
-
-
Freedman, B.S.1
Lam, A.Q.2
Sundsbak, J.L.3
Iatrino, R.4
Su, X.5
Koon, S.J.6
Wu, M.7
Daheron, L.8
Harris, P.C.9
Zhou, J.10
-
85
-
-
84865434169
-
Induced pluripotent stem cells generated from diabetic patients with mitochondrial DNA A3243G mutation
-
Fujikura, J.; Nakao, K.; Sone, M.; Noguchi, M.; Mori, E.; Naito, M.; Taura, D.; Harada-Shiba, M.; Kishimoto, I.; Watanabe, A. et al. Induced pluripotent stem cells generated from diabetic patients with mitochondrial DNA A3243G mutation. Diabetologia 2012, 55, 1689–1698.
-
(2012)
Diabetologia
, vol.55
, pp. 1689-1698
-
-
Fujikura, J.1
Nakao, K.2
Sone, M.3
Noguchi, M.4
Mori, E.5
Naito, M.6
Taura, D.7
Harada-Shiba, M.8
Kishimoto, I.9
Watanabe, A.10
-
86
-
-
84925695495
-
Impaired respiratory function in MELAS-induced pluripotent stem cells with high heteroplasmy levels
-
Kodaira, M.; Hatakeyama, H.; Yuasa, S.; Seki, T.; Egashira, T.; Tohyama, S.; Kuroda, Y.; Tanaka, A.; Okata, S.; Hashimoto, H. et al. Impaired respiratory function in MELAS-induced pluripotent stem cells with high heteroplasmy levels. FEBS Open Biol. 2015, 5, 219–225.
-
(2015)
FEBS Open Biol
, vol.5
, pp. 219-225
-
-
Kodaira, M.1
Hatakeyama, H.2
Yuasa, S.3
Seki, T.4
Egashira, T.5
Tohyama, S.6
Kuroda, Y.7
Tanaka, A.8
Okata, S.9
Hashimoto, H.10
-
87
-
-
84863229339
-
A human stem cell model of early Alzheimer’s disease pathology in down syndrome
-
Shi, Y.; Kirwan, P.; Smith, J.; MacLean, G.; Orkin, S.H.; Livesey, F.J. A human stem cell model of early Alzheimer’s disease pathology in down syndrome. Sci. Transl. Med. 2012, 4, doi: 10.1126/scitranslmed.3003771.
-
(2012)
Sci. Transl. Med
, pp. 4
-
-
Shi, Y.1
Kirwan, P.2
Smith, J.3
Maclean, G.4
Orkin, S.H.5
Livesey, F.J.6
-
88
-
-
84881668417
-
Translating dosage compensation to trisomy 21
-
Jiang, J.; Jing, Y.; Cost, G.J.; Chiang, J.C.; Kolpa, H.J.; Cotton, A.M.; Carone, D.M.; Carone, B.R.; Shivak, D.A.; Guschin, D.Y. et al. Translating dosage compensation to trisomy 21. Nature 2013, 500, 296–300.
-
(2013)
Nature
, vol.500
, pp. 296-300
-
-
Jiang, J.1
Jing, Y.2
Cost, G.J.3
Chiang, J.C.4
Kolpa, H.J.5
Cotton, A.M.6
Carone, D.M.7
Carone, B.R.8
Shivak, D.A.9
Guschin, D.Y.10
-
89
-
-
79960009804
-
Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies
-
Mazzulli, J.R.; Xu, Y.H.; Sun, Y.; Knight, A.L.; McLean, P.J.; Caldwell, G.A.; Sidransky, E.; Grabowski, G.A.; Krainc, D. Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies. Cell 2011, 146, 37–52.
-
(2011)
Cell
, vol.146
, pp. 37-52
-
-
Mazzulli, J.R.1
Xu, Y.H.2
Sun, Y.3
Knight, A.L.4
McLean, P.J.5
Caldwell, G.A.6
Sidransky, E.7
Grabowski, G.A.8
Krainc, D.9
-
90
-
-
81855172517
-
Human Pompe disease-induced pluripotent stem cells for pathogenesis modeling, drug testing and disease marker identification
-
Huang, H.P.; Chen, P.H.; Hwu, W.L.; Chuang, C.Y.; Chien, Y.H.; Stone, L.; Chien, C.L.; Li, L.T.; Chiang, S.C.; Chen, H.F. et al. Human Pompe disease-induced pluripotent stem cells for pathogenesis modeling, drug testing and disease marker identification. Hum. Mol. Genet. 2011, 20, 4851–4864.
-
(2011)
Hum. Mol. Genet
, vol.20
, pp. 4851-4864
-
-
Huang, H.P.1
Chen, P.H.2
Hwu, W.L.3
Chuang, C.Y.4
Chien, Y.H.5
Stone, L.6
Chien, C.L.7
Li, L.T.8
Chiang, S.C.9
Chen, H.F.10
-
91
-
-
84868089871
-
Induced pluripotent stem cell model recapitulates pathologic hallmarks of gaucher disease
-
Panicker, L.M.; Miller, D.; Park, T.S.; Patel, B.; Azevedo, J.L.; Awad, O.; Masood, M.A.; Veenstra, T.D.; Goldin, E.; Stubblefield, B.K. et al. Induced pluripotent stem cell model recapitulates pathologic hallmarks of gaucher disease. Proc. Natl. Acad. Sci. USA 2012, 109, 18054–18059.
-
(2012)
Proc. Natl. Acad. Sci. USA
, vol.109
, pp. 18054-18059
-
-
Panicker, L.M.1
Miller, D.2
Park, T.S.3
Patel, B.4
Azevedo, J.L.5
Awad, O.6
Masood, M.A.7
Veenstra, T.D.8
Goldin, E.9
Stubblefield, B.K.10
-
92
-
-
78650995671
-
A human iPSC model of Hutchinson Gilford Progeria reveals vascular smooth muscle and mesenchymal stem cell defects
-
Zhang, J.; Lian, Q.; Zhu, G.; Zhou, F.; Sui, L.; Tan, C.; Mutalif, R.A.; Navasankari, R.; Zhang, Y.; Tse, H.F. et al. A human iPSC model of Hutchinson Gilford Progeria reveals vascular smooth muscle and mesenchymal stem cell defects. Cell Stem Cell 2011, 8, 31–45.
-
(2011)
Cell Stem Cell
, vol.8
, pp. 31-45
-
-
Zhang, J.1
Lian, Q.2
Zhu, G.3
Zhou, F.4
Sui, L.5
Tan, C.6
Mutalif, R.A.7
Navasankari, R.8
Zhang, Y.9
Tse, H.F.10
-
93
-
-
79954626173
-
Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford Progeria syndrome
-
Liu, G.H.; Barkho, B.Z.; Ruiz, S.; Diep, D.; Qu, J.; Yang, S.L.; Panopoulos, A.D.; Suzuki, K.; Kurian, L.; Walsh, C. et al. Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford Progeria syndrome. Nature 2011, 472, 221–225.
-
(2011)
Nature
, vol.472
, pp. 221-225
-
-
Liu, G.H.1
Barkho, B.Z.2
Ruiz, S.3
Diep, D.4
Qu, J.5
Yang, S.L.6
Panopoulos, A.D.7
Suzuki, K.8
Kurian, L.9
Walsh, C.10
-
94
-
-
79955884485
-
Modelling schizophrenia using human induced pluripotent stem cells
-
Brennand, K.J.; Simone, A.; Jou, J.; Gelboin-Burkhart, C.; Tran, N.; Sangar, S.; Li, Y.; Mu, Y.; Chen, G.; Yu, D. et al. Modelling schizophrenia using human induced pluripotent stem cells. Nature 2011, 473, 221–225.
-
(2011)
Nature
, vol.473
, pp. 221-225
-
-
Brennand, K.J.1
Simone, A.2
Jou, J.3
Gelboin-Burkhart, C.4
Tran, N.5
Sangar, S.6
Li, Y.7
Mu, Y.8
Chen, G.9
Yu, D.10
-
95
-
-
33846677129
-
-
BMJ
-
Perel, P.; Roberts, I.; Sena, E.; Wheble, P.; Briscoe, C.; Sandercock, P.; Macleod, M.; Mignini, L.E.; Jayaram, P.; Khan, K.S. Comparison of treatment effects between animal experiments and clinical trials: Systematic review. BMJ 2007, 334, doi:10.1136/bmj.39048.407928.BE.
-
(2007)
Comparison of Treatment Effects between Animal Experiments and Clinical Trials: Systematic Review
, pp. 334
-
-
Perel, P.1
Roberts, I.2
Sena, E.3
Wheble, P.4
Briscoe, C.5
Sandercock, P.6
Macleod, M.7
Mignini, L.E.8
Jayaram, P.9
Khan, K.S.10
-
96
-
-
84874741888
-
Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs
-
Kim, C.; Wong, J.; Wen, J.; Wang, S.; Wang, C.; Spiering, S.; Kan, N.G.; Forcales, S.; Puri, P.L.; Leone, T.C. et al. Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs. Nature 2013, 494, 105–110.
-
(2013)
Nature
, vol.494
, pp. 105-110
-
-
Kim, C.1
Wong, J.2
Wen, J.3
Wang, S.4
Wang, C.5
Spiering, S.6
Kan, N.G.7
Forcales, S.8
Puri, P.L.9
Leone, T.C.10
-
97
-
-
84876522952
-
Generation of patient-specific induced pluripotent stem cell-derived cardiomyocytes as a cellular model of arrhythmogenic right ventricular cardiomyopathy
-
Ma, D.; Wei, H.; Lu, J.; Ho, S.; Zhang, G.; Sun, X.; Oh, Y.; Tan, S.H.; Ng, M.L.; Shim, W. et al. Generation of patient-specific induced pluripotent stem cell-derived cardiomyocytes as a cellular model of arrhythmogenic right ventricular cardiomyopathy. Eur. Heart J. 2013, 34, 1122–1133.
-
(2013)
Eur. Heart J
, vol.34
, pp. 1122-1133
-
-
Ma, D.1
Wei, H.2
Lu, J.3
Ho, S.4
Zhang, G.5
Sun, X.6
Oh, Y.7
Tan, S.H.8
Ng, M.L.9
Shim, W.10
-
98
-
-
84892415382
-
Modeling of arrhythmogenic right ventricular cardiomyopathy with human induced pluripotent stem cells. Circ. Cardiovasc
-
Caspi, O.; Huber, I.; Gepstein, A.; Arbel, G.; Maizels, L.; Boulos, M.; Gepstein, L. Modeling of arrhythmogenic right ventricular cardiomyopathy with human induced pluripotent stem cells. Circ. Cardiovasc. Genet. 2013, 6, 557–568.
-
(2013)
Genet
, vol.6
, pp. 557-568
-
-
Caspi, O.1
Huber, I.2
Gepstein, A.3
Arbel, G.4
Maizels, L.5
Boulos, M.6
Gepstein, L.7
-
99
-
-
83755195408
-
In vitro modeling of ryanodine receptor 2 dysfunction using human induced pluripotent stem cells
-
Fatima, A.; Xu, G.; Shao, K.; Papadopoulos, S.; Lehmann, M.; Arnaiz-Cot, J.J.; Rosa, A.O.; Nguemo, F.; Matzkies, M.; Dittmann, S. et al. In vitro modeling of ryanodine receptor 2 dysfunction using human induced pluripotent stem cells. Cell. Physiol. Biochem. 2011, 28, 579–592.
-
(2011)
Cell. Physiol. Biochem
, vol.28
, pp. 579-592
-
-
Fatima, A.1
Xu, G.2
Shao, K.3
Papadopoulos, S.4
Lehmann, M.5
Arnaiz-Cot, J.J.6
Rosa, A.O.7
Nguemo, F.8
Matzkies, M.9
Dittmann, S.10
-
100
-
-
84858129398
-
Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia
-
Jung, C.B.; Moretti, A.; Mederos Schnitzler, M.; Iop, L.; Storch, U.; Bellin, M.; Dorn, T.; Ruppenthal, S.; Pfeiffer, S.; Goedel, A. et al. Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia. EMBO Mol. Med. 2012, 4, 180–191.
-
(2012)
EMBO Mol. Med
, vol.4
, pp. 180-191
-
-
Jung, C.B.1
Moretti, A.2
Mederos Schnitzler, M.3
Iop, L.4
Storch, U.5
Bellin, M.6
Dorn, T.7
Ruppenthal, S.8
Pfeiffer, S.9
Goedel, A.10
-
101
-
-
84857547828
-
Cardiomyocytes generated from CPVTD307H patients are arrhythmogenic in response to β-adrenergic stimulation
-
Novak, A.; Barad, L.; Zeevi-Levin, N.; Shick, R.; Shtrichman, R.; Lorber, A.; Itskovitz-Eldor, J.; Binah, O. Cardiomyocytes generated from CPVTD307H patients are arrhythmogenic in response to β-adrenergic stimulation. J. Cell. Mol. Med. 2012, 16, 468–482.
-
(2012)
J. Cell. Mol. Med
, vol.16
, pp. 468-482
-
-
Novak, A.1
Barad, L.2
Zeevi-Levin, N.3
Shick, R.4
Shtrichman, R.5
Lorber, A.6
Itskovitz-Eldor, J.7
Binah, O.8
-
102
-
-
84866033059
-
Cell model of catecholaminergic polymorphic ventricular tachycardia reveals early and delayed afterdepolarizations
-
Kujala, K.; Paavola, J.; Lahti, A.; Larsson, K.; Pekkanen-Mattila, M.; Viitasalo, M.; Lahtinen, A.M.; Toivonen, L.; Kontula, K.; Swan, H. et al. Cell model of catecholaminergic polymorphic ventricular tachycardia reveals early and delayed afterdepolarizations. PLoS ONE 2012, 7, e44660.
-
(2012)
Plos ONE
, vol.7
, pp. 44660
-
-
Kujala, K.1
Paavola, J.2
Lahti, A.3
Larsson, K.4
Pekkanen-Mattila, M.5
Viitasalo, M.6
Lahtinen, A.M.7
Toivonen, L.8
Kontula, K.9
Swan, H.10
-
103
-
-
84865801030
-
Modeling of catecholaminergic polymorphic ventricular tachycardia with patient-specific human-induced pluripotent stem cells
-
Itzhaki, I.; Maizels, L.; Huber, I.; Gepstein, A.; Arbel, G.; Caspi, O.; Miller, L.; Belhassen, B.; Nof, E.; Glikson, M. et al. Modeling of catecholaminergic polymorphic ventricular tachycardia with patient-specific human-induced pluripotent stem cells. J. Am. Coll. Cardiol. 2012, 60, 990–1000.
-
(2012)
J. Am. Coll. Cardiol
, vol.60
, pp. 990-1000
-
-
Itzhaki, I.1
Maizels, L.2
Huber, I.3
Gepstein, A.4
Arbel, G.5
Caspi, O.6
Miller, L.7
Belhassen, B.8
Nof, E.9
Glikson, M.10
-
104
-
-
84880513096
-
Ca2+ signaling in human induced pluripotent stem cell-derived cardiomyocytes (IPS-CM) from normal and catecholaminergic polymorphic ventricular tachycardia (CPVT)-afflicted subjects
-
Zhang, X.H.; Haviland, S.; Wei, H.; Saric, T.; Fatima, A.; Hescheler, J.; Cleemann, L.; Morad, M. Ca2+ signaling in human induced pluripotent stem cell-derived cardiomyocytes (iPS-CM) from normal and catecholaminergic polymorphic ventricular tachycardia (CPVT)-afflicted subjects. Cell Calcium 2013, 54, 57–70.
-
(2013)
Cell Calcium
, vol.54
, pp. 57-70
-
-
Zhang, X.H.1
Haviland, S.2
Wei, H.3
Saric, T.4
Fatima, A.5
Hescheler, J.6
Cleemann, L.7
Morad, M.8
-
105
-
-
84887454024
-
Camkii inhibition rectifies arrhythmic phenotype in a patient-specific model of catecholaminergic polymorphic ventricular tachycardia
-
Di Pasquale, E.; Lodola, F.; Miragoli, M.; Denegri, M.; Avelino-Cruz, J.E.; Buonocore, M.; Nakahama, H.; Portararo, P.; Bloise, R.; Napolitano, C. et al. Camkii inhibition rectifies arrhythmic phenotype in a patient-specific model of catecholaminergic polymorphic ventricular tachycardia. Cell Death Dis. 2013, 4, doi:10.1038/cddis.2013.369.
-
(2013)
Cell Death Dis
, vol.4
-
-
Di Pasquale, E.1
Lodola, F.2
Miragoli, M.3
Denegri, M.4
Avelino-Cruz, J.E.5
Buonocore, M.6
Nakahama, H.7
Portararo, P.8
Bloise, R.9
Napolitano, C.10
-
106
-
-
80052100421
-
Generation of induced pluripotent stem cell lines from 3 distinct laminopathies bearing heterogeneous mutations in lamin A/C
-
Ho, J.C.; Zhou, T.; Lai, W.H.; Huang, Y.; Chan, Y.C.; Li, X.; Wong, N.L.; Li, Y.; Au, K.W.; Guo, D. et al. Generation of induced pluripotent stem cell lines from 3 distinct laminopathies bearing heterogeneous mutations in lamin A/C. Aging (Albany NY) 2011, 3, 380–390.
-
(2011)
Aging (Albany NY)
, vol.3
, pp. 380-390
-
-
Ho, J.C.1
Zhou, T.2
Lai, W.H.3
Huang, Y.4
Chan, Y.C.5
Li, X.6
Wong, N.L.7
Li, Y.8
Au, K.W.9
Guo, D.10
-
107
-
-
84872506168
-
Modeling of lamin A/C mutation premature cardiac aging using patient-specific induced pluripotent stem cells
-
Siu, C.W.; Lee, Y.K.; Ho, J.C.; Lai, W.H.; Chan, Y.C.; Ng, K.M.; Wong, L.Y.; Au, K.W.; Lau, Y.M.; Zhang, J. et al. Modeling of lamin A/C mutation premature cardiac aging using patient-specific induced pluripotent stem cells. Aging (Albany NY) 2012, 4, 803–822.
-
(2012)
Aging (Albany NY)
, vol.4
, pp. 803-822
-
-
Siu, C.W.1
Lee, Y.K.2
Ho, J.C.3
Lai, W.H.4
Chan, Y.C.5
Ng, K.M.6
Wong, L.Y.7
Au, K.W.8
Lau, Y.M.9
Zhang, J.10
-
108
-
-
84860156650
-
Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy
-
Sun, N.; Yazawa, M.; Liu, J.; Han, L.; Sanchez-Freire, V.; Abilez, O.J.; Navarrete, E.G.; Hu, S.; Wang, L.; Lee, A. et al. Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy. Sci. Transl. Med. 2012, 4, doi:10.1126/scitranslmed.3003552.
-
(2012)
Sci. Transl. Med
, pp. 4
-
-
Sun, N.1
Yazawa, M.2
Liu, J.3
Han, L.4
Sanchez-Freire, V.5
Abilez, O.J.6
Navarrete, E.G.7
Hu, S.8
Wang, L.9
Lee, A.10
-
109
-
-
84875276852
-
Patient-specific induced-pluripotent stem cells-derived cardiomyocytes recapitulate the pathogenic phenotypes of dilated cardiomyopathy due to a novel DES mutation identified by whole exome sequencing
-
Tse, H.F.; Ho, J.C.; Choi, S.W.; Lee, Y.K.; Butler, A.W.; Ng, K.M.; Siu, C.W.; Simpson, M.A.; Lai, W.H.; Chan, Y.C. et al. Patient-specific induced-pluripotent stem cells-derived cardiomyocytes recapitulate the pathogenic phenotypes of dilated cardiomyopathy due to a novel DES mutation identified by whole exome sequencing. Hum. Mol. Genet. 2013, 22, 1395–1403.
-
(2013)
Hum. Mol. Genet
, vol.22
, pp. 1395-1403
-
-
Tse, H.F.1
Ho, J.C.2
Choi, S.W.3
Lee, Y.K.4
Butler, A.W.5
Ng, K.M.6
Siu, C.W.7
Simpson, M.A.8
Lai, W.H.9
Chan, Y.C.10
-
110
-
-
84872026086
-
Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells
-
Lan, F.; Lee, A.S.; Liang, P.; Sanchez-Freire, V.; Nguyen, P.K.; Wang, L.; Han, L.; Yen, M.; Wang, Y.; Sun, N. et al. Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells. Cell Stem Cell 2013, 12, 101–113.
-
(2013)
Cell Stem Cell
, vol.12
, pp. 101-113
-
-
Lan, F.1
Lee, A.S.2
Liang, P.3
Sanchez-Freire, V.4
Nguyen, P.K.5
Wang, L.6
Han, L.7
Yen, M.8
Wang, Y.9
Sun, N.10
-
111
-
-
84913590117
-
Study familial hypertrophic cardiomyopathy using patient-specific induced pluripotent stem cells
-
Han, L.; Li, Y.; Tchao, J.; Kaplan, A.D.; Lin, B.; Li, Y.; Mich-Basso, J.; Lis, A.; Hassan, N.; London, B. et al. Study familial hypertrophic cardiomyopathy using patient-specific induced pluripotent stem cells. Cardiovasc. Res. 2014, 104, 258–269.
-
(2014)
Cardiovasc. Res
, vol.104
, pp. 258-269
-
-
Han, L.1
Li, Y.2
Tchao, J.3
Kaplan, A.D.4
Lin, B.5
Li, Y.6
Mich-Basso, J.7
Lis, A.8
Hassan, N.9
London, B.10
-
112
-
-
84925833680
-
Endothelin-1 induces myofibrillar disarray and contractile vector variability in hypertrophic cardiomyopathy-induced pluripotent stem cell-derived cardiomyocytes
-
Tanaka, A.; Yuasa, S.; Mearini, G.; Egashira, T.; Seki, T.; Kodaira, M.; Kusumoto, D.; Kuroda, Y.; Okata, S.; Suzuki, T. et al. Endothelin-1 induces myofibrillar disarray and contractile vector variability in hypertrophic cardiomyopathy-induced pluripotent stem cell-derived cardiomyocytes. J. Am. Heart Assoc. 2014, 3, 001263.
-
(2014)
J. Am. Heart Assoc
, vol.3
, pp. 001263
-
-
Tanaka, A.1
Yuasa, S.2
Mearini, G.3
Egashira, T.4
Seki, T.5
Kodaira, M.6
Kusumoto, D.7
Kuroda, Y.8
Okata, S.9
Suzuki, T.10
-
113
-
-
84879493450
-
Cardiolipin deficiency affects respiratory chain function and organization in an induced pluripotent stem cell model of Barth syndrome
-
Dudek, J.; Cheng, I.F.; Balleininger, M.; Vaz, F.M.; Streckfuss-Bomeke, K.; Hubscher, D.; Vukotic, M.; Wanders, R.J.; Rehling, P.; Guan, K. Cardiolipin deficiency affects respiratory chain function and organization in an induced pluripotent stem cell model of Barth syndrome. Stem Cell Res. 2013, 11, 806–819.
-
(2013)
Stem Cell Res
, vol.11
, pp. 806-819
-
-
Dudek, J.1
Cheng, I.F.2
Balleininger, M.3
Vaz, F.M.4
Streckfuss-Bomeke, K.5
Hubscher, D.6
Vukotic, M.7
Wanders, R.J.8
Rehling, P.9
Guan, K.10
-
114
-
-
84901642000
-
Functional analysis of iPSC-derived myocytes from a patient with carnitine palmitoyltransferase II deficiency
-
Yasuno, T.; Osafune, K.; Sakurai, H.; Asaka, I.; Tanaka, A.; Yamaguchi, S.; Yamada, K.; Hitomi, H.; Arai, S.; Kurose, Y. et al. Functional analysis of iPSC-derived myocytes from a patient with carnitine palmitoyltransferase II deficiency. Biochem. Biophys. Res. Commun. 2014, 448, 175–181.
-
(2014)
Biochem. Biophys. Res. Commun
, vol.448
, pp. 175-181
-
-
Yasuno, T.1
Osafune, K.2
Sakurai, H.3
Asaka, I.4
Tanaka, A.5
Yamaguchi, S.6
Yamada, K.7
Hitomi, H.8
Arai, S.9
Kurose, Y.10
-
115
-
-
79960331887
-
Generation of induced pluripotent stem cell lines from friedreich ataxia patients
-
Liu, J.; Verma, P.J.; Evans-Galea, M.V.; Delatycki, M.B.; Michalska, A.; Leung, J.; Crombie, D.; Sarsero, J.P.; Williamson, R.; Dottori, M. et al. Generation of induced pluripotent stem cell lines from friedreich ataxia patients. Stem Cell Rev. 2011, 7, 703–713.
-
(2011)
Stem Cell Rev
, vol.7
, pp. 703-713
-
-
Liu, J.1
Verma, P.J.2
Evans-Galea, M.V.3
Delatycki, M.B.4
Michalska, A.5
Leung, J.6
Crombie, D.7
Sarsero, J.P.8
Williamson, R.9
Dottori, M.10
-
116
-
-
84877830055
-
Neurons and cardiomyocytes derived from induced pluripotent stem cells as a model for mitochondrial defects in Friedreich’s ataxia
-
Hick, A.; Wattenhofer-Donze, M.; Chintawar, S.; Tropel, P.; Simard, J.P.; Vaucamps, N.; Gall, D.; Lambot, L.; Andre, C.; Reutenauer, L. et al. Neurons and cardiomyocytes derived from induced pluripotent stem cells as a model for mitochondrial defects in Friedreich’s ataxia. Dis. Model. Mech. 2013, 6, 608–621.
-
(2013)
Dis. Model. Mech
, vol.6
, pp. 608-621
-
-
Hick, A.1
Wattenhofer-Donze, M.2
Chintawar, S.3
Tropel, P.4
Simard, J.P.5
Vaucamps, N.6
Gall, D.7
Lambot, L.8
Andre, C.9
Reutenauer, L.10
-
117
-
-
84905719998
-
Modeling of Friedreich ataxia-related iron overloading cardiomyopathy using patient-specific-induced pluripotent stem cells
-
Lee, Y.K.; Ho, P.W.; Schick, R.; Lau, Y.M.; Lai, W.H.; Zhou, T.; Li, Y.; Ng, K.M.; Ho, S.L.; Esteban, M.A. et al. Modeling of Friedreich ataxia-related iron overloading cardiomyopathy using patient-specific-induced pluripotent stem cells. Pflugers Arch. 2014, 466, 1831–1844.
-
(2014)
Pflugers Arch
, vol.466
, pp. 1831-1844
-
-
Lee, Y.K.1
Ho, P.W.2
Schick, R.3
Lau, Y.M.4
Lai, W.H.5
Zhou, T.6
Li, Y.7
Ng, K.M.8
Ho, S.L.9
Esteban, M.A.10
-
118
-
-
77953443251
-
Patient-specific induced pluripotent stem-cell-de rived models of LEOPARD syndrome
-
Carvajal-Vergara, X.; Sevilla, A.; D’Souza, S.L.; Ang, Y.S.; Schaniel, C.; Lee, D.F.; Yang, L.; Kaplan, A.D.; Adler, E.D.; Rozov, R. et al. Patient-specific induced pluripotent stem-cell-de rived models of LEOPARD syndrome. Nature 2010, 465, 808–812.
-
(2010)
Nature
, vol.465
, pp. 808-812
-
-
Carvajal-Vergara, X.1
Sevilla, A.2
D’Souza, S.L.3
Ang, Y.S.4
Schaniel, C.5
Lee, D.F.6
Yang, L.7
Kaplan, A.D.8
Adler, E.D.9
Rozov, R.10
-
119
-
-
77957729169
-
Patient-specific induced pluripotent stem-cell models for long-QT syndrome
-
Moretti, A.; Bellin, M.; Welling, A.; Jung, C.B.; Lam, J.T.; Bott-Flugel, L.; Dorn, T.; Goedel, A.; Hohnke, C.; Hofmann, F. et al. Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N. Engl. J. Med. 2010, 363, 1397–1409.
-
(2010)
N. Engl. J. Med
, vol.363
, pp. 1397-1409
-
-
Moretti, A.1
Bellin, M.2
Welling, A.3
Jung, C.B.4
Lam, J.T.5
Bott-Flugel, L.6
Dorn, T.7
Goedel, A.8
Hohnke, C.9
Hofmann, F.10
-
120
-
-
84865254838
-
Disease characterization using LQTS-specific induced pluripotent stem cells
-
Egashira, T.; Yuasa, S.; Suzuki, T.; Aizawa, Y.; Yamakawa, H.; Matsuhashi, T.; Ohno, Y.; Tohyama, S.; Okata, S.; Seki, T. et al. Disease characterization using LQTS-specific induced pluripotent stem cells. Cardiovasc. Res. 2012, 95, 419–429.
-
(2012)
Cardiovasc. Res
, vol.95
, pp. 419-429
-
-
Egashira, T.1
Yuasa, S.2
Suzuki, T.3
Aizawa, Y.4
Yamakawa, H.5
Matsuhashi, T.6
Ohno, Y.7
Tohyama, S.8
Okata, S.9
Seki, T.10
-
121
-
-
79952446402
-
Modelling the long QT syndrome with induced pluripotent stem cells
-
Itzhaki, I.; Maizels, L.; Huber, I.; Zwi-Dantsis, L.; Caspi, O.; Winterstern, A.; Feldman, O.; Gepstein, A.; Arbel, G.; Hammerman, H. et al. Modelling the long QT syndrome with induced pluripotent stem cells. Nature 2011, 471, 225–229.
-
(2011)
Nature
, vol.471
, pp. 225-229
-
-
Itzhaki, I.1
Maizels, L.2
Huber, I.3
Zwi-Dantsis, L.4
Caspi, O.5
Winterstern, A.6
Feldman, O.7
Gepstein, A.8
Arbel, G.9
Hammerman, H.10
-
122
-
-
79954523845
-
Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation
-
Matsa, E.; Rajamohan, D.; Dick, E.; Young, L.; Mellor, I.; Staniforth, A.; Denning, C. Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation. Eur. Heart J. 2011, 32, 952–962.
-
(2011)
Eur. Heart J
, vol.32
, pp. 952-962
-
-
Matsa, E.1
Rajamohan, D.2
Dick, E.3
Young, L.4
Mellor, I.5
Staniforth, A.6
Denning, C.7
-
123
-
-
84858040591
-
Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture
-
Lahti, A.L.; Kujala, V.J.; Chapman, H.; Koivisto, A.P.; Pekkanen-Mattila, M.; Kerkela, E.; Hyttinen, J.; Kontula, K.; Swan, H.; Conklin, B.R. et al. Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture. Dis. Model. Mech. 2012, 5, 220–230.
-
(2012)
Dis. Model. Mech
, vol.5
, pp. 220-230
-
-
Lahti, A.L.1
Kujala, V.J.2
Chapman, H.3
Koivisto, A.P.4
Pekkanen-Mattila, M.5
Kerkela, E.6
Hyttinen, J.7
Kontula, K.8
Swan, H.9
Conklin, B.R.10
-
124
-
-
84875084211
-
The generation of induced pluripotent stem cells from a patient with KCNH2 G603D, without LQT2 disease associated symptom
-
Okata, S.; Yuasa, S.; Yamane, T.; Furukawa, T.; Fukuda, K. The generation of induced pluripotent stem cells from a patient with KCNH2 G603D, without LQT2 disease associated symptom. J. Med. Dent. Sci. 2013, 60, 17–22.
-
(2013)
J. Med. Dent. Sci
, vol.60
, pp. 17-22
-
-
Okata, S.1
Yuasa, S.2
Yamane, T.3
Furukawa, T.4
Fukuda, K.5
-
125
-
-
84899514041
-
Interference rescues the long-QT syndrome phenotype in human-induced pluripotency stem cell cardiomyocytes
-
Matsa, E.; Dixon, J.E.; Medway, C.; Georgiou, O.; Patel, M.J.; Morgan, K.; Kemp, P.J.; Staniforth, A.; Mellor, I.; Denning, C. Allele-specific RNA interference rescues the long-QT syndrome phenotype in human-induced pluripotency stem cell cardiomyocytes. Eur. Heart J. 2014, 35, 1078–1087.
-
(2014)
Eur. Heart J
, vol.35
, pp. 1078-1087
-
-
Matsa, E.1
Dixon, J.E.2
Medway, C.3
Georgiou, O.4
Patel, M.J.5
Morgan, K.6
Kemp, P.J.7
Staniforth, A.8
Mellor, I.9
Denning, C.10
Allele-Specific, R.11
-
126
-
-
84872238836
-
Induced pluripotent stem cells used to reveal drug actions in a long QT syndrome family with complex genetics
-
Terrenoire, C.; Wang, K.; Tung, K.W.; Chung, W.K.; Pass, R.H.; Lu, J.T.; Jean, J.C.; Omari, A.; Sampson, K.J.; Kotton, D.N. et al. Induced pluripotent stem cells used to reveal drug actions in a long QT syndrome family with complex genetics. J. Gen. Physiol. 2013, 141, 61–72.
-
(2013)
J. Gen. Physiol
, vol.141
, pp. 61-72
-
-
Terrenoire, C.1
Wang, K.2
Tung, K.W.3
Chung, W.K.4
Pass, R.H.5
Lu, J.T.6
Jean, J.C.7
Omari, A.8
Sampson, K.J.9
Kotton, D.N.10
-
127
-
-
84887150722
-
Modeling type 3 long QT syndrome with cardiomyocytes derived from patient-specific induced pluripotent stem cells
-
Ma, D.; Wei, H.; Zhao, Y.; Lu, J.; Li, G.; Sahib, N.B.; Tan, T.H.; Wong, K.Y.; Shim, W.; Wong, P. et al. Modeling type 3 long QT syndrome with cardiomyocytes derived from patient-specific induced pluripotent stem cells. Int. J. Cardiol. 2013, 168, 5277–5286.
-
(2013)
Int. J. Cardiol
, vol.168
, pp. 5277-5286
-
-
Ma, D.1
Wei, H.2
Zhao, Y.3
Lu, J.4
Li, G.5
Sahib, N.B.6
Tan, T.H.7
Wong, K.Y.8
Shim, W.9
Wong, P.10
-
128
-
-
84863213874
-
Cardiomyocytes derived from pluripotent stem cells recapitulate electrophysiological characteristics of an overlap syndrome of cardiac sodium channel disease
-
Davis, R.P.; Casini, S.; van den Berg, C.W.; Hoekstra, M.; Remme, C.A.; Dambrot, C.; Salvatori, D.; Oostwaard, D.W.; Wilde, A.A.; Bezzina, C.R. et al. Cardiomyocytes derived from pluripotent stem cells recapitulate electrophysiological characteristics of an overlap syndrome of cardiac sodium channel disease. Circulation 2012, 125, 3079–3091.
-
(2012)
Circulation
, vol.125
, pp. 3079-3091
-
-
Davis, R.P.1
Casini, S.2
Van Den Berg, C.W.3
Hoekstra, M.4
Remme, C.A.5
Dambrot, C.6
Salvatori, D.7
Oostwaard, D.W.8
Wilde, A.A.9
Bezzina, C.R.10
-
129
-
-
79952438377
-
Using induced pluripotent stem cells to investigate cardiac phenotypes in timothy syndrome
-
Yazawa, M.; Hsueh, B.; Jia, X.; Pasca, A.M.; Bernstein, J.A.; Hallmayer, J.; Dolmetsch, R.E. Using induced pluripotent stem cells to investigate cardiac phenotypes in timothy syndrome. Nature 2011, 471, 230–234.
-
(2011)
Nature
, vol.471
, pp. 230-234
-
-
Yazawa, M.1
Hsueh, B.2
Jia, X.3
Pasca, A.M.4
Bernstein, J.A.5
Hallmayer, J.6
Dolmetsch, R.E.7
-
130
-
-
84870325682
-
Exogenous activation of BMP-2 signaling overcomes TGFβ-mediated inhibition of osteogenesis in marfan embryonic stem cells and marfan patient-specific induced pluripotent stem cells
-
Quarto, N.; Li, S.; Renda, A.; Longaker, M.T. Exogenous activation of BMP-2 signaling overcomes TGFβ-mediated inhibition of osteogenesis in marfan embryonic stem cells and marfan patient-specific induced pluripotent stem cells. Stem Cells 2012, 30, 2709–2719.
-
(2012)
Stem Cells
, vol.30
, pp. 2709-2719
-
-
Quarto, N.1
Li, S.2
Renda, A.3
Longaker, M.T.4
-
131
-
-
84867007532
-
Modeling supravalvular aortic stenosis syndrome with human induced pluripotent stem cells
-
Ge, X.; Ren, Y.; Bartulos, O.; Lee, M.Y.; Yue, Z.; Kim, K.Y.; Li, W.; Amos, P.J.; Bozkulak, E.C.; Iyer, A. et al. Modeling supravalvular aortic stenosis syndrome with human induced pluripotent stem cells. Circulation 2012, 126, 1695–1704.
-
(2012)
Circulation
, vol.126
, pp. 1695-1704
-
-
Ge, X.1
Ren, Y.2
Bartulos, O.3
Lee, M.Y.4
Yue, Z.5
Kim, K.Y.6
Li, W.7
Amos, P.J.8
Bozkulak, E.C.9
Iyer, A.10
-
132
-
-
80054968938
-
Refining repolarization reserve
-
Roden, D.M.; Abraham, R.L. Refining repolarization reserve. Heart Rhythm 2011, 8, 1756–1757.
-
(2011)
Heart Rhythm
, vol.8
, pp. 1756-1757
-
-
Roden, D.M.1
Abraham, R.L.2
-
133
-
-
5344223383
-
Cav1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism
-
Splawski, I.; Timothy, K.W.; Sharpe, L.M.; Decher, N.; Kumar, P.; Bloise, R.; Napolitano, C.; Schwartz, P.J.; Joseph, R.M.; Condouris, K. et al. Cav1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 2004, 119, 19–31.
-
(2004)
Cell
, vol.119
, pp. 19-31
-
-
Splawski, I.1
Timothy, K.W.2
Sharpe, L.M.3
Decher, N.4
Kumar, P.5
Bloise, R.6
Napolitano, C.7
Schwartz, P.J.8
Joseph, R.M.9
Condouris, K.10
-
134
-
-
0035895322
-
Mutations in the cardiac ryanodine receptor gene (HRyR2) underlie catecholaminergic polymorphic ventricular tachycardia
-
Priori, S.G.; Napolitano, C.; Tiso, N.; Memmi, M.; Vignati, G.; Bloise, R.; Sorrentino, V.; Danieli, G.A. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 2001, 103, 196–200.
-
(2001)
Circulation
, vol.103
, pp. 196-200
-
-
Priori, S.G.1
Napolitano, C.2
Tiso, N.3
Memmi, M.4
Vignati, G.5
Bloise, R.6
Sorrentino, V.7
Danieli, G.A.8
-
135
-
-
0035205336
-
A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in bedouin families from Israel
-
Lahat, H.; Pras, E.; Olender, T.; Avidan, N.; Ben-Asher, E.; Man, O.; Levy-Nissenbaum, E.; Khoury, A.; Lorber, A.; Goldman, B. et al. A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in bedouin families from Israel. Am. J. Hum. Genet. 2001, 69, 1378–1384.
-
(2001)
Am. J. Hum. Genet
, vol.69
, pp. 1378-1384
-
-
Lahat, H.1
Pras, E.2
Olender, T.3
Avidan, N.4
Ben-Asher, E.5
Man, O.6
Levy-Nissenbaum, E.7
Khoury, A.8
Lorber, A.9
Goldman, B.10
-
136
-
-
33646693410
-
Contemporary definitions and classification of the cardiomyopathies: An american heart association scientific statement from the council on clinical cardiology, heart failure and transplantation committee; quality of care and outcomes research and functional genomics and translational biology interdisciplinary working groups; and council on epidemiology and prevention
-
Maron, B.J.; Towbin, J.A.; Thiene, G.; Antzelevitch, C.; Corrado, D.; Arnett, D.; Moss, A.J.; Seidman, C.E.; Young, J.B. Contemporary definitions and classification of the cardiomyopathies: An american heart association scientific statement from the council on clinical cardiology, heart failure and transplantation committee; quality of care and outcomes research and functional genomics and translational biology interdisciplinary working groups; and council on epidemiology and prevention. Circulation 2006, 113, 1807–1816.
-
(2006)
Circulation
, vol.113
, pp. 1807-1816
-
-
Maron, B.J.1
Towbin, J.A.2
Thiene, G.3
Antzelevitch, C.4
Corrado, D.5
Arnett, D.6
Moss, A.J.7
Seidman, C.E.8
Young, J.B.9
-
137
-
-
38349086961
-
Classification of the cardiomyopathies: A position statement from the european society of cardiology working group on myocardial and pericardial diseases
-
Elliott, P.; Andersson, B.; Arbustini, E.; Bilinska, Z.; Cecchi, F.; Charron, P.; Dubourg, O.; Kuhl, U.; Maisch, B.; McKenna, W.J. et al. Classification of the cardiomyopathies: A position statement from the european society of cardiology working group on myocardial and pericardial diseases. Eur. Heart J. 2008, 29, 270–276.
-
(2008)
Eur. Heart J
, vol.29
, pp. 270-276
-
-
Elliott, P.1
Andersson, B.2
Arbustini, E.3
Bilinska, Z.4
Cecchi, F.5
Charron, P.6
Dubourg, O.7
Kuhl, U.8
Maisch, B.9
McKenna, W.J.10
-
138
-
-
76149084859
-
Role of A-type lamins in signaling, transcription, and chromatin organization
-
Andres, V.; Gonzalez, J.M. Role of A-type lamins in signaling, transcription, and chromatin organization. J. Cell Biol. 2009, 187, 945–957.
-
(2009)
J. Cell Biol
, vol.187
, pp. 945-957
-
-
Andres, V.1
Gonzalez, J.M.2
-
139
-
-
0033534053
-
Restoration of contractile function in isolated cardiomyocytes from failing human hearts by gene transfer of SERCA2a
-
Del Monte, F.; Harding, S.E.; Schmidt, U.; Matsui, T.; Kang, Z.B.; Dec, G.W.; Gwathmey, J.K.; Rosenzweig, A.; Hajjar, R.J. Restoration of contractile function in isolated cardiomyocytes from failing human hearts by gene transfer of SERCA2a. Circulation 1999, 100, 2308–2311.
-
(1999)
Circulation
, vol.100
, pp. 2308-2311
-
-
Del Monte, F.1
Harding, S.E.2
Schmidt, U.3
Matsui, T.4
Kang, Z.B.5
Dec, G.W.6
Gwathmey, J.K.7
Rosenzweig, A.8
Hajjar, R.J.9
-
140
-
-
12944332074
-
Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure
-
Miyamoto, M.I.; del Monte, F.; Schmidt, U.; DiSalvo, T.S.; Kang, Z.B.; Matsui, T.; Guerrero, J.L.; Gwathmey, J.K.; Rosenzweig, A.; Hajjar, R.J. Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure. Proc. Natl. Acad. Sci. USA 2000, 97, 793–798.
-
(2000)
Proc. Natl. Acad. Sci. USA
, vol.97
, pp. 793-798
-
-
Miyamoto, M.I.1
Del Monte, F.2
Schmidt, U.3
Disalvo, T.S.4
Kang, Z.B.5
Matsui, T.6
Guerrero, J.L.7
Gwathmey, J.K.8
Rosenzweig, A.9
Hajjar, R.J.10
-
141
-
-
10744224342
-
Transgenic rat hearts overexpressing SERCA2a show improved contractility under baseline conditions and pressure overload
-
Muller, O.J.; Lange, M.; Rattunde, H.; Lorenzen, H.P.; Muller, M.; Frey, N.; Bittner, C.; Simonides, W.; Katus, H.A.; Franz, W.M. Transgenic rat hearts overexpressing SERCA2a show improved contractility under baseline conditions and pressure overload. Cardiovasc. Res. 2003,59, 380–389.
-
(2003)
Cardiovasc. Res
, vol.59
, pp. 380-389
-
-
Muller, O.J.1
Lange, M.2
Rattunde, H.3
Lorenzen, H.P.4
Muller, M.5
Frey, N.6
Bittner, C.7
Simonides, W.8
Katus, H.A.9
Franz, W.M.10
-
142
-
-
77649170228
-
Molecular basis of hereditary cardiomyopathy: Abnormalities in calcium sensitivity, stretch response, stress response and beyond
-
Kimura, A. Molecular basis of hereditary cardiomyopathy: Abnormalities in calcium sensitivity, stretch response, stress response and beyond. J. Hum. Genet. 2010, 55, 81–90.
-
(2010)
J. Hum. Genet
, vol.55
, pp. 81-90
-
-
Kimura, A.1
-
143
-
-
78650688851
-
Mutation type is not clinically useful in predicting prognosis in hypertrophic cardiomyopathy
-
Landstrom, A.P.; Ackerman, M.J. Mutation type is not clinically useful in predicting prognosis in hypertrophic cardiomyopathy. Circulation 2010, 122, 2441–2450.
-
(2010)
Circulation
, vol.122
, pp. 2441-2450
-
-
Landstrom, A.P.1
Ackerman, M.J.2
-
144
-
-
0029083650
-
Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the cardia study. Coronary artery risk development in (young) adults
-
Maron, B.J.; Gardin, J.M.; Flack, J.M.; Gidding, S.S.; Kurosaki, T.T.; Bild, D.E. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the cardia study. Coronary artery risk development in (young) adults. Circulation 1995, 92, 785–789.
-
(1995)
Circulation
, vol.92
, pp. 785-789
-
-
Maron, B.J.1
Gardin, J.M.2
Flack, J.M.3
Gidding, S.S.4
Kurosaki, T.T.5
Bild, D.E.6
-
145
-
-
0025040392
-
Molecular basis for familial hypertrophic cardiomyopathy
-
Geisterfer-Lowrance, A.A.; Kass, S.; Tanigawa, G.; Vosberg, H.P.; McKenna, W.; Seidman, C.E.; Seidman, J.G. A molecular basis for familial hypertrophic cardiomyopathy: A β cardiac myosin heavy chain gene missense mutation. Cell 1990, 62, 999–1006.
-
(1990)
A β Cardiac Myosin Heavy Chain Gene Missense Mutation. Cell
, vol.62
, pp. 999-1006
-
-
Geisterfer-Lowrance, A.A.1
Kass, S.2
Tanigawa, G.3
Vosberg, H.P.4
McKenna, W.5
Seidman, C.E.6
Seidman, J.7
-
146
-
-
79955519460
-
Inherited cardiomyopathies
-
Watkins, H.; Ashrafian, H.; Redwood, C. Inherited cardiomyopathies. N. Engl. J. Med. 2011, 364, 1643–1656.
-
(2011)
N. Engl. J. Med
, vol.364
, pp. 1643-1656
-
-
Watkins, H.1
Ashrafian, H.2
Redwood, C.3
-
147
-
-
0033979552
-
Pathogenesis of diverse clinical and pathological phenotypes in hypertrophic cardiomyopathy
-
Marian, A.J. Pathogenesis of diverse clinical and pathological phenotypes in hypertrophic cardiomyopathy. Lancet 2000, 355, 58–60.
-
(2000)
Lancet
, vol.355
, pp. 58-60
-
-
Marian, A.J.1
-
148
-
-
35548997132
-
Role of genetic analysis in the management of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy
-
Sen-Chowdhry, S.; Syrris, P.; McKenna, W.J. Role of genetic analysis in the management of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J. Am. Coll. Cardiol. 2007, 50, 1813–1821.
-
(2007)
J. Am. Coll. Cardiol
, vol.50
, pp. 1813-1821
-
-
Sen-Chowdhry, S.1
Syrris, P.2
McKenna, W.J.3
-
149
-
-
42649092901
-
Mechanisms of disease: Molecular genetics of arrhythmogenic right ventricular dysplasia/cardiomyopathy
-
Awad, M.M.; Calkins, H.; Judge, D.P. Mechanisms of disease: Molecular genetics of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Nat. Clin. Pract. Cardiovasc. Med. 2008, 5, 258–267.
-
(2008)
Nat. Clin. Pract. Cardiovasc. Med
, vol.5
, pp. 258-267
-
-
Awad, M.M.1
Calkins, H.2
Judge, D.P.3
-
150
-
-
84875226936
-
Molecular and metabolic mechanisms of cardiac dysfunction in diabetes
-
Mandavia, C.H.; Aroor, A.R.; Demarco, V.G.; Sowers, J.R. Molecular and metabolic mechanisms of cardiac dysfunction in diabetes. Life Sci. 2013, 92, 601–608.
-
(2013)
Life Sci
, vol.92
, pp. 601-608
-
-
Mandavia, C.H.1
Aroor, A.R.2
Demarco, V.G.3
Sowers, J.R.4
-
151
-
-
84898920521
-
Diabetic cardiomyopathy: Mechanisms and new treatment strategies targeting antioxidant signaling pathways. Pharmacol
-
Huynh, K.; Bernardo, B.C.; McMullen, J.R.; Ritchie, R.H. Diabetic cardiomyopathy: Mechanisms and new treatment strategies targeting antioxidant signaling pathways. Pharmacol. Ther. 2014, 142, 375–415.
-
(2014)
Ther
, vol.142
, pp. 375-415
-
-
Huynh, K.1
Bernardo, B.C.2
McMullen, J.R.3
Ritchie, R.H.4
-
152
-
-
84876570848
-
Concise review: Maturation phases of human pluripotent stem cell-derived cardiomyocytes
-
Robertson, C.; Tran, D.D.; George, S.C. Concise review: Maturation phases of human pluripotent stem cell-derived cardiomyocytes. Stem Cells 2013, 31, 829–837.
-
(2013)
Stem Cells
, vol.31
, pp. 829-837
-
-
Robertson, C.1
Tran, D.D.2
George, S.C.3
-
153
-
-
84884364320
-
Human-induced pluripotent stem cell-derived cardiomyocytes exhibit temporal changes in phenotype
-
Ivashchenko, C.Y.; Pipes, G.C.; Lozinskaya, I.M.; Lin, Z.; Xiaoping, X.; Needle, S.; Grygielko, E.T.; Hu, E.; Toomey, J.R.; Lepore, J.J. et al. Human-induced pluripotent stem cell-derived cardiomyocytes exhibit temporal changes in phenotype. Am. J. Physiol. Heart Circ. Physiol. 2013, 305, H913–H922.
-
(2013)
Am. J. Physiol. Heart Circ. Physiol
, vol.305
, pp. 913-922
-
-
Ivashchenko, C.Y.1
Pipes, G.C.2
Lozinskaya, I.M.3
Lin, Z.4
Xiaoping, X.5
Needle, S.6
Grygielko, E.T.7
Hu, E.8
Toomey, J.R.9
Lepore, J.J.10
-
154
-
-
84893395943
-
Developmental cues for the maturation of metabolic, electrophysiological and calcium handling properties of human pluripotent stem cell-derived cardiomyocytes
-
Keung, W.; Boheler, K.R.; Li, R.A. Developmental cues for the maturation of metabolic, electrophysiological and calcium handling properties of human pluripotent stem cell-derived cardiomyocytes. Stem Cell Res. Ther. 2014, 5, doi:10.1186/scrt406.
-
(2014)
Stem Cell Res. Ther
, pp. 5
-
-
Keung, W.1
Boheler, K.R.2
Li, R.A.3
-
155
-
-
84894160639
-
Engineering adolescence: Maturation of human pluripotent stem cell-derived cardiomyocytes
-
Yang, X.; Pabon, L.; Murry, C.E. Engineering adolescence: Maturation of human pluripotent stem cell-derived cardiomyocytes. Circ. Res. 2014, 114, 511–523.
-
(2014)
Circ. Res
, vol.114
, pp. 511-523
-
-
Yang, X.1
Pabon, L.2
Murry, C.E.3
-
156
-
-
84892884582
-
Lessons from the heart: Mirroring electrophysiological characteristics during cardiac development to in vitro differentiation of stem cell derived cardiomyocytes
-
Van den Heuvel, N.H.; van Veen, T.A.; Lim, B.; Jonsson, M.K. Lessons from the heart: Mirroring electrophysiological characteristics during cardiac development to in vitro differentiation of stem cell derived cardiomyocytes. J. Mol. Cell. Cardiol. 2014, 67, 12–25.
-
(2014)
J. Mol. Cell. Cardiol
, vol.67
, pp. 12-25
-
-
Van Den Heuvel, N.H.1
Van Veen, T.A.2
Lim, B.3
Jonsson, M.K.4
-
157
-
-
0345303845
-
Assessment of the ultrastructural and proliferative properties of human embryonic stem cell-derived cardiomyocytes
-
Snir, M.; Kehat, I.; Gepstein, A.; Coleman, R.; Itskovitz-Eldor, J.; Livne, E.; Gepstein, L. Assessment of the ultrastructural and proliferative properties of human embryonic stem cell-derived cardiomyocytes. Am. J. Physiol. Heart Circ. Physiol. 2003, 285, H2355–H2363.
-
(2003)
Am. J. Physiol. Heart Circ. Physiol
, vol.285
, pp. 2355-2363
-
-
Snir, M.1
Kehat, I.2
Gepstein, A.3
Coleman, R.4
Itskovitz-Eldor, J.5
Livne, E.6
Gepstein, L.7
-
158
-
-
80054935074
-
Cardiomyocytes derived from human embryonic and induced pluripotent stem cells: Comparative ultrastructure
-
Gherghiceanu, M.; Barad, L.; Novak, A.; Reiter, I.; Itskovitz-Eldor, J.; Binah, O.; Popescu, L.M. Cardiomyocytes derived from human embryonic and induced pluripotent stem cells: Comparative ultrastructure. J. Cell. Mol. Med. 2011, 15, 2539–2551.
-
(2011)
J. Cell. Mol. Med
, vol.15
, pp. 2539-2551
-
-
Gherghiceanu, M.1
Barad, L.2
Novak, A.3
Reiter, I.4
Itskovitz-Eldor, J.5
Binah, O.6
Popescu, L.M.7
-
159
-
-
79151484284
-
Modulation of human embryonic stem cell-derived cardiomyocyte growth: A testbed for studying human cardiac hypertrophy
-
Foldes, G.; Mioulane, M.; Wright, J.S.; Liu, A.Q.; Novak, P.; Merkely, B.; Gorelik, J.; Schneider, M.D.; Ali, N.N.; Harding, S.E. Modulation of human embryonic stem cell-derived cardiomyocyte growth: A testbed for studying human cardiac hypertrophy? J. Mol. Cell. Cardiol. 2011, 50, 367–376.
-
(2011)
J. Mol. Cell. Cardiol
, vol.50
, pp. 367-376
-
-
Foldes, G.1
Mioulane, M.2
Wright, J.S.3
Liu, A.Q.4
Novak, P.5
Merkely, B.6
Gorelik, J.7
Schneider, M.D.8
Ali, N.N.9
Harding, S.E.10
-
160
-
-
84880227000
-
Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells
-
Lundy, S.D.; Zhu, W.Z.; Regnier, M.; Laflamme, M.A. Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells. Stem Cells Dev. 2013, 22, 1991–2002.
-
(2013)
Stem Cells Dev
, vol.22
, pp. 1991-2002
-
-
Lundy, S.D.1
Zhu, W.Z.2
Regnier, M.3
Laflamme, M.A.4
-
161
-
-
84876755488
-
Ultrastructural maturation of human-induced pluripotent stem cell-derived cardiomyocytes in a long-term culture
-
Kamakura, T.; Makiyama, T.; Sasaki, K.; Yoshida, Y.; Wuriyanghai, Y.; Chen, J.; Hattori, T.; Ohno, S.; Kita, T.; Horie, M. et al. Ultrastructural maturation of human-induced pluripotent stem cell-derived cardiomyocytes in a long-term culture. Circ. J. 2013, 77, 1307–1314.
-
(2013)
Circ. J
, vol.77
, pp. 1307-1314
-
-
Kamakura, T.1
Makiyama, T.2
Sasaki, K.3
Yoshida, Y.4
Wuriyanghai, Y.5
Chen, J.6
Hattori, T.7
Ohno, S.8
Kita, T.9
Horie, M.10
-
162
-
-
84862282455
-
Effects of substrate mechanics on contractility of cardiomyocytes generated from human pluripotent stem cells
-
Hazeltine, L.B.; Simmons, C.S.; Salick, M.R.; Lian, X.; Badur, M.G.; Han, W.; Delgado, S.M.; Wakatsuki, T.; Crone, W.C.; Pruitt, B.L. et al. Effects of substrate mechanics on contractility of cardiomyocytes generated from human pluripotent stem cells. Int. J. Cell Biol. 2012, 2012, doi:10.1155/2012/508294
-
(2012)
Int. J. Cell Biol
, pp. 2012
-
-
Hazeltine, L.B.1
Simmons, C.S.2
Salick, M.R.3
Lian, X.4
Badur, M.G.5
Han, W.6
Delgado, S.M.7
Wakatsuki, T.8
Crone, W.C.9
Pruitt, B.L.10
-
163
-
-
84890462515
-
Electrical stimulation promotes maturation of cardiomyocytes derived from human embryonic stem cells
-
Chan, Y.C.; Ting, S.; Lee, Y.K.; Ng, K.M.; Zhang, J.; Chen, Z.; Siu, C.W.; Oh, S.K.; Tse, H.F. Electrical stimulation promotes maturation of cardiomyocytes derived from human embryonic stem cells. J. Cardiovasc. Transl. Res. 2013, 6, 989–999.
-
(2013)
J. Cardiovasc. Transl. Res
, vol.6
, pp. 989-999
-
-
Chan, Y.C.1
Ting, S.2
Lee, Y.K.3
Ng, K.M.4
Zhang, J.5
Chen, Z.6
Siu, C.W.7
Oh, S.K.8
Tse, H.F.9
-
164
-
-
34247589595
-
Control of stress-dependent cardiac growth and gene expression by a microRNA
-
Van Rooij, E.; Sutherland, L.B.; Qi, X.; Richardson, J.A.; Hill, J.; Olson, E.N. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 2007, 316, 575–579.
-
(2007)
Science
, vol.316
, pp. 575-579
-
-
Van Rooij, E.1
Sutherland, L.B.2
Qi, X.3
Richardson, J.A.4
Hill, J.5
Olson, E.N.6
-
165
-
-
77956127107
-
Triiodothyronine promotes cardiac differentiation and maturation of embryonic stem cells via the classical genomic pathway
-
Lee, Y.K.; Ng, K.M.; Chan, Y.C.; Lai, W.H.; Au, K.W.; Ho, C.Y.; Wong, L.Y.; Lau, C.P.; Tse, H.F.; Siu, C.W. Triiodothyronine promotes cardiac differentiation and maturation of embryonic stem cells via the classical genomic pathway. Mol. Endocrinol. 2010, 24, 1728–1736.
-
(2010)
Mol. Endocrinol
, vol.24
, pp. 1728-1736
-
-
Lee, Y.K.1
Ng, K.M.2
Chan, Y.C.3
Lai, W.H.4
Au, K.W.5
Ho, C.Y.6
Wong, L.Y.7
Lau, C.P.8
Tse, H.F.9
Siu, C.W.10
-
166
-
-
84924874555
-
Functional maturation of human pluripotent stem cell derived cardiomyocytes in vitro—Correlation between contraction force and electrophysiology
-
Ribeiro, M.C.; Tertoolen, L.G.; Guadix, J.A.; Bellin, M.; Kosmidis, G.; D’Aniello, C.; Monshouwer-Kloots, J.; Goumans, M.J.; Wang, Y.L.; Feinberg, A.W. et al. Functional maturation of human pluripotent stem cell derived cardiomyocytes in vitro—Correlation between contraction force and electrophysiology. Biomaterials 2015, 51, 138–150.
-
(2015)
Biomaterials
, vol.51
, pp. 138-150
-
-
Ribeiro, M.C.1
Tertoolen, L.G.2
Guadix, J.A.3
Bellin, M.4
Kosmidis, G.5
D’Aniello, C.6
Monshouwer-Kloots, J.7
Goumans, M.J.8
Wang, Y.L.9
Feinberg, A.W.10
-
167
-
-
84862777929
-
Clinical applications of patient-specific induced pluripotent stem cells in cardiovascular medicine
-
Oh, Y.; Wei, H.; Ma, D.; Sun, X.; Liew, R. Clinical applications of patient-specific induced pluripotent stem cells in cardiovascular medicine. Heart 2012, 98, 443–449.
-
(2012)
Heart
, vol.98
, pp. 443-449
-
-
Oh, Y.1
Wei, H.2
Ma, D.3
Sun, X.4
Liew, R.5
-
168
-
-
54349117790
-
Retinoid acid-induced effects on atrial and pacemaker cell differentiation and expression of cardiac ion channels
-
Gassanov, N.; Er, F.; Zagidullin, N.; Jankowski, M.; Gutkowska, J.; Hoppe, U.C. Retinoid acid-induced effects on atrial and pacemaker cell differentiation and expression of cardiac ion channels. Differentiation 2008, 76, 971–980.
-
(2008)
Differentiation
, vol.76
, pp. 971-980
-
-
Gassanov, N.1
Er, F.2
Zagidullin, N.3
Jankowski, M.4
Gutkowska, J.5
Hoppe, U.C.6
-
169
-
-
79954418253
-
Direct differentiation of atrial and ventricular myocytes from human embryonic stem cells by alternating retinoid signals
-
Zhang, Q.; Jiang, J.; Han, P.; Yuan, Q.; Zhang, J.; Zhang, X.; Xu, Y.; Cao, H.; Meng, Q.; Chen, L. et al. Direct differentiation of atrial and ventricular myocytes from human embryonic stem cells by alternating retinoid signals. Cell Res. 2011, 21, 579–587.
-
(2011)
Cell Res
, vol.21
, pp. 579-587
-
-
Zhang, Q.1
Jiang, J.2
Han, P.3
Yuan, Q.4
Zhang, J.5
Zhang, X.6
Xu, Y.7
Cao, H.8
Meng, Q.9
Chen, L.10
-
170
-
-
84855499199
-
Primitive cardiac cells from human embryonic stem cells
-
Hudson, J.; Titmarsh, D.; Hidalgo, A.; Wolvetang, E.; Cooper-White, J. Primitive cardiac cells from human embryonic stem cells. Stem Cells Dev. 2012, 21, 1513–1523.
-
(2012)
Stem Cells Dev
, vol.21
, pp. 1513-1523
-
-
Hudson, J.1
Titmarsh, D.2
Hidalgo, A.3
Wolvetang, E.4
Cooper-White, J.5
-
171
-
-
84867746044
-
Extracellular matrix promotes highly efficient cardiac differentiation of human pluripotent stem cells: The matrix sandwich method
-
Zhang, J.; Klos, M.; Wilson, G.F.; Herman, A.M.; Lian, X.; Raval, K.K.; Barron, M.R.; Hou, L.; Soerens, A.G.; Yu, J. et al. Extracellular matrix promotes highly efficient cardiac differentiation of human pluripotent stem cells: The matrix sandwich method. Circ. Res. 2012, 111, 1125–1136.
-
(2012)
Circ. Res
, vol.111
, pp. 1125-1136
-
-
Zhang, J.1
Klos, M.2
Wilson, G.F.3
Herman, A.M.4
Lian, X.5
Raval, K.K.6
Barron, M.R.7
Hou, L.8
Soerens, A.G.9
Yu, J.10
-
172
-
-
84884954445
-
Myosin light chain 2-based selection of human iPSC-derived early ventricular cardiac myocytes
-
Bizy, A.; Guerrero-Serna, G.; Hu, B.; Ponce-Balbuena, D.; Willis, B.C.; Zarzoso, M.; Ramirez, R.J.; Sener, M.F.; Mundada, L.V.; Klos, M. et al. Myosin light chain 2-based selection of human iPSC-derived early ventricular cardiac myocytes. Stem Cell Res. 2013, 11, 1335–1347.
-
(2013)
Stem Cell Res
, vol.11
, pp. 1335-1347
-
-
Bizy, A.1
Guerrero-Serna, G.2
Hu, B.3
Ponce-Balbuena, D.4
Willis, B.C.5
Zarzoso, M.6
Ramirez, R.J.7
Sener, M.F.8
Mundada, L.V.9
Klos, M.10
-
173
-
-
84872048038
-
Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes
-
Tohyama, S.; Hattori, F.; Sano, M.; Hishiki, T.; Nagahata, Y.; Matsuura, T.; Hashimoto, H.; Suzuki, T.; Yamashita, H.; Satoh, Y. et al. Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes. Cell Stem Cell 2013, 12, 127–137.
-
(2013)
Cell Stem Cell
, vol.12
, pp. 127-137
-
-
Tohyama, S.1
Hattori, F.2
Sano, M.3
Hishiki, T.4
Nagahata, Y.5
Matsuura, T.6
Hashimoto, H.7
Suzuki, T.8
Yamashita, H.9
Satoh, Y.10
-
174
-
-
84913525381
-
A massive suspension culture system with metabolic purification for human pluripotent stem cell-derived cardiomyocytes
-
Hemmi, N.; Tohyama, S.; Nakajima, K.; Kanazawa, H.; Suzuki, T.; Hattori, F.; Seki, T.; Kishino, Y.; Hirano, A.; Okada, M. et al. A massive suspension culture system with metabolic purification for human pluripotent stem cell-derived cardiomyocytes. Stem Cells Transl. Med. 2014, 3, 1473–1483.
-
(2014)
Stem Cells Transl. Med
, vol.3
, pp. 1473-1483
-
-
Hemmi, N.1
Tohyama, S.2
Nakajima, K.3
Kanazawa, H.4
Suzuki, T.5
Hattori, F.6
Seki, T.7
Kishino, Y.8
Hirano, A.9
Okada, M.10
-
175
-
-
77956696064
-
Isolation, differentiation and characterization of vascular cells derived from human embryonic stem cells
-
Levenberg, S.; Ferreira, L.S.; Chen-Konak, L.; Kraehenbuehl, T.P.; Langer, R. Isolation, differentiation and characterization of vascular cells derived from human embryonic stem cells. Nat. Protoc. 2010, 5, 1115–1126.
-
(2010)
Nat. Protoc
, vol.5
, pp. 1115-1126
-
-
Levenberg, S.1
Ferreira, L.S.2
Chen-Konak, L.3
Kraehenbuehl, T.P.4
Langer, R.5
-
176
-
-
84865270424
-
High-purity enrichment of functional cardiovascular cells from human iPS cells
-
Lin, B.; Kim, J.; Li, Y.; Pan, H.; Carvajal-Vergara, X.; Salama, G.; Cheng, T.; Li, Y.; Lo, C.W.; Yang, L. High-purity enrichment of functional cardiovascular cells from human iPS cells. Cardiovasc. Res. 2012, 95, 327–335.
-
(2012)
Cardiovasc. Res
, vol.95
, pp. 327-335
-
-
Lin, B.1
Kim, J.2
Li, Y.3
Pan, H.4
Carvajal-Vergara, X.5
Salama, G.6
Cheng, T.7
Li, Y.8
Lo, C.W.9
Yang, L.10
-
177
-
-
84901847622
-
Generation, expansion and functional analysis of endothelial cells and pericytes derived from human pluripotent stem cells
-
Orlova, V.V.; van den Hil, F.E.; Petrus-Reurer, S.; Drabsch, Y.; Ten Dijke, P.; Mummery, C.L. Generation, expansion and functional analysis of endothelial cells and pericytes derived from human pluripotent stem cells. Nat. Protoc. 2014, 9, 1514–1531.
-
(2014)
Nat. Protoc
, vol.9
, pp. 1514-1531
-
-
Orlova, V.V.1
Van Den Hil, F.E.2
Petrus-Reurer, S.3
Drabsch, Y.4
Ten Dijke, P.5
Mummery, C.L.6
-
178
-
-
84895473350
-
Cardiac tissue engineering: State of the art
-
Hirt, M.N.; Hansen, A.; Eschenhagen, T. Cardiac tissue engineering: State of the art. Circ. Res. 2014, 114, 354–367.
-
(2014)
Circ. Res
, vol.114
, pp. 354-367
-
-
Hirt, M.N.1
Hansen, A.2
Eschenhagen, T.3
-
179
-
-
77954760209
-
Development of a drug screening platform based on engineered heart tissue
-
Hansen, A.; Eder, A.; Bonstrup, M.; Flato, M.; Mewe, M.; Schaaf, S.; Aksehirlioglu, B.; Schwoerer, A.P.; Uebeler, J.; Eschenhagen, T. Development of a drug screening platform based on engineered heart tissue. Circ. Res. 2010, 107, 35–44.
-
(2010)
Circ. Res
, vol.107
, pp. 35-44
-
-
Hansen, A.1
Eder, A.2
Bonstrup, M.3
Flato, M.4
Mewe, M.5
Schaaf, S.6
Aksehirlioglu, B.7
Schwoerer, A.P.8
Uebeler, J.9
Eschenhagen, T.10
-
180
-
-
84900549462
-
Automated analysis of contractile force and Ca2+ transients in engineered heart tissue
-
Stoehr, A.; Neuber, C.; Baldauf, C.; Vollert, I.; Friedrich, F.W.; Flenner, F.; Carrier, L.; Eder, A.; Schaaf, S.; Hirt, M.N. et al. Automated analysis of contractile force and Ca2+ transients in engineered heart tissue. Am. J. Physiol. Heart Circ. Physiol. 2014, 306, 1353–1363.
-
(2014)
Am. J. Physiol. Heart Circ. Physiol
, vol.306
, pp. 1353-1363
-
-
Stoehr, A.1
Neuber, C.2
Baldauf, C.3
Vollert, I.4
Friedrich, F.W.5
Flenner, F.6
Carrier, L.7
Eder, A.8
Schaaf, S.9
Hirt, M.N.10
-
181
-
-
84904753518
-
Functional improvement and maturation of rat and human engineered heart tissue by chronic electrical stimulation
-
Hirt, M.N.; Boeddinghaus, J.; Mitchell, A.; Schaaf, S.; Bornchen, C.; Muller, C.; Schulz, H.; Hubner, N.; Stenzig, J.; Stoehr, A. et al. Functional improvement and maturation of rat and human engineered heart tissue by chronic electrical stimulation. J. Mol. Cell. Cardiol. 2014, 74, 151–161.
-
(2014)
J. Mol. Cell. Cardiol
, vol.74
, pp. 151-161
-
-
Hirt, M.N.1
Boeddinghaus, J.2
Mitchell, A.3
Schaaf, S.4
Bornchen, C.5
Muller, C.6
Schulz, H.7
Hubner, N.8
Stenzig, J.9
Stoehr, A.10
-
182
-
-
84908486306
-
The role of tissue engineering and biomaterials in cardiac regenerative medicine
-
Zhao, Y.; Feric, N.T.; Thavandiran, N.; Nunes, S.S.; Radisic, M. The role of tissue engineering and biomaterials in cardiac regenerative medicine. Can. J. Cardiol. 2014, 30, 1307–1322.
-
(2014)
Can. J. Cardiol
, vol.30
, pp. 1307-1322
-
-
Zhao, Y.1
Feric, N.T.2
Thavandiran, N.3
Nunes, S.S.4
Radisic, M.5
-
183
-
-
0037040160
-
Tissue engineering of a differentiated cardiac muscle construct. Circ
-
Zimmermann, W.H.; Schneiderbanger, K.; Schubert, P.; Didie, M.; Munzel, F.; Heubach, J.F.; Kostin, S.; Neuhuber, W.L.; Eschenhagen, T. Tissue engineering of a differentiated cardiac muscle construct. Circ. Res. 2002, 90, 223–230.
-
(2002)
Res
, vol.90
, pp. 223-230
-
-
Zimmermann, W.H.1
Schneiderbanger, K.2
Schubert, P.3
Didie, M.4
Munzel, F.5
Heubach, J.F.6
Kostin, S.7
Neuhuber, W.L.8
Eschenhagen, T.9
-
184
-
-
84883277066
-
Contractile abnormalities and altered drug response in engineered heart tissue from Mybpc3-targeted knock-in mice
-
Stohr, A.; Friedrich, F.W.; Flenner, F.; Geertz, B.; Eder, A.; Schaaf, S.; Hirt, M.N.; Uebeler, J.; Schlossarek, S.; Carrier, L. et al. Contractile abnormalities and altered drug response in engineered heart tissue from Mybpc3-targeted knock-in mice. J. Mol. Cell. Cardiol. 2013, 63, 189–198.
-
(2013)
J. Mol. Cell. Cardiol
, vol.63
, pp. 189-198
-
-
Stohr, A.1
Friedrich, F.W.2
Flenner, F.3
Geertz, B.4
Eder, A.5
Schaaf, S.6
Hirt, M.N.7
Uebeler, J.8
Schlossarek, S.9
Carrier, L.10
-
185
-
-
84881480907
-
Biowire: A platform for maturation of human pluripotent stem cell-derived cardiomyocytes
-
Nunes, S.S.; Miklas, J.W.; Liu, J.; Aschar-Sobbi, R.; Xiao, Y.; Zhang, B.; Jiang, J.; Masse, S.; Gagliardi, M.; Hsieh, A. et al. Biowire: A platform for maturation of human pluripotent stem cell-derived cardiomyocytes. Nat. Methods 2013, 10, 781–787.
-
(2013)
Nat. Methods
, vol.10
, pp. 781-787
-
-
Nunes, S.S.1
Miklas, J.W.2
Liu, J.3
Aschar-Sobbi, R.4
Xiao, Y.5
Zhang, B.6
Jiang, J.7
Masse, S.8
Gagliardi, M.9
Hsieh, A.10
-
186
-
-
79960023610
-
Growth of engineered human myocardium with mechanical loading and vascular coculture
-
Tulloch, N.L.; Muskheli, V.; Razumova, M.V.; Korte, F.S.; Regnier, M.; Hauch, K.D.; Pabon, L.; Reinecke, H.; Murry, C.E. Growth of engineered human myocardium with mechanical loading and vascular coculture. Circ. Res. 2011, 109, 47–59.
-
(2011)
Circ. Res
, vol.109
, pp. 47-59
-
-
Tulloch, N.L.1
Muskheli, V.2
Razumova, M.V.3
Korte, F.S.4
Regnier, M.5
Hauch, K.D.6
Pabon, L.7
Reinecke, H.8
Murry, C.E.9
-
187
-
-
84912058337
-
Multi-cellular interactions sustain long-term contractility of human pluripotent stem cell-derived cardiomyocytes
-
Burridge, P.W.; Metzler, S.A.; Nakayama, K.H.; Abilez, O.J.; Simmons, C.S.; Bruce, M.A.; Matsuura, Y.; Kim, P.; Wu, J.C.; Butte, M. et al. Multi-cellular interactions sustain long-term contractility of human pluripotent stem cell-derived cardiomyocytes. Am. J. Transl. Res. 2014, 6, 724–735.
-
(2014)
Am. J. Transl. Res
, vol.6
, pp. 724-735
-
-
Burridge, P.W.1
Metzler, S.A.2
Nakayama, K.H.3
Abilez, O.J.4
Simmons, C.S.5
Bruce, M.A.6
Matsuura, Y.7
Kim, P.8
Wu, J.C.9
Butte, M.10
|